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1. INTRODUCTION   
1.1 Ceramide generation and ceramide-enriched membrane domains 
1.1.1 Lipid interactions and domain formation 
The plasma membrane of mammalian cells consists primarily of (glycero) phospholipids, 
sphingolipids and cholesterol (Hakomori, 1983). The classic fluid mosaic model, 
introduced by Singer and Nicolson in 1972, predicts free movement of proteins in the lipid 
bilayer; this model was based on biophysical experiments that determined the melting 
temperatures of lipids (Singer and Nicolson, 1972). However, in the past 10 to 15 years, 
this concept has been revised; it currently indicates that lipids in cell membranes do not 
form a homogenous liquid phase, but are ordered into distinct membrane domains that are 
enriched by sphingolipids and cholesterol (Simons and Ikonen, 1997). 
 
Sphingolipids consist of a hydrophobic ceramide moiety and a hydrophilic headgroup. The 
ceramide moiety is composed of D-erythro-sphingosine and a fatty acid whose acyl chain 
contains 2 to 28 carbon atoms and is connected via an amide ester bond. Ceramides are 
further modified by attachments of headgroups to form, for instance, sphingomyelin, 
gangliosides, sulfatides, globosides or cerebrosides. Sphingomyelin is the most prevalent 
cellular sphingolipid, which is synthesized on the luminal side of the Golgi apparatus or 
the plasma membrane, and, thus, localizes predominantly to anti-cytoplasmic leaflets of the 
cell membrane and intracellular vesicles (Jeckel et al., 1990; Futerman et al., 1990). This 
distribution pattern of sphingomyelin results in lipid bilayer asymmetry, which is critical 
for the genesis of distinct membrane domains and, as discussed below, signal transduction. 
Sphingomyelin is comprised of a highly hydrophobic ceramide moiety and a hydrophilic 
phosphorylcholine headgroup (Barenholz and Thompson, 1980; Kolesnick et al., 2000). 
The hydrophilic phosphorylcholine groups tightly interact with each other, other 
hydrophilic headgroups of glycosphingolipids and the hydrophilic parts of cholesterol. The 
ceramide moiety of sphingomyelin binds to cholesterol via hydrophobic van der Waal 
interactions (Simons and Ikonen, 1997; Harder and Simons, 1997; Brown and London, 
1998). The tight hydrophilic and hydrophobic interactions and the high local concentration 
of sphingolipids and cholesterol mediate a lateral association of these lipids in the cell 
membrane, separation from other phospholipids within the bilayer and the spontaneous 
formation of distinct domains (Simons et al., 1997; Harder and Simons, 1997; Brown and 
Introduction 
 
2 
London, 1998). These very small, tightly packed sphingolipid- and cholesterol-enriched 
membrane domains are named rafts that seem to exist in a more ordered liquid phase than 
other parts of the cell membrane (Simons and Ikonen, 1997; Harder and Simons, 1997; 
Brown and London, 1998) (Figure 1.1). Recent microscopy studies demonstrated that the 
size of these rafts is approximately 20 nm (Eggeling et al., 2009). Cholesterol and some 
cholesterol precursors do not only interact with sphingolipids in these rafts, but also 
stabilize the structure of rafts by filling void spaces between the bulky sphingolipids 
(Harder and Simons, 1997; Xu et al., 2001). This notion is consistent with the finding that 
extraction of cholesterol from membranes using drugs as beta-cyclodextrin, nystatin or 
filipin that binds cholesterol, destroys membrane rafts (Keller and Simons, 1998). Many 
studies characterized rafts by their resistance to detergents, which are caused by the high 
biophysical order in this phase, although the use of detergents might be problematic to 
investigate the physiology of lipids and detergent-resistant membrane domains are not the 
same as membrane rafts (Munro, 2003; Lichtenberg et al., 2005). 
 
 
Figure 1.1 Membrane lipid raft structure and componets.  
Membrane lipid rafts consist of dynamic assemblies of cholesterol and lipids with saturated fatty 
acid chains, sphingolipids and glycosphingolipids in the outside membrane of lipid bilayer and 
phospholipid with saturated chains in the inner membrane. These sphingolipids and phospholipids 
interact with cholesterol and form a tightly packed lipid microdomain. These lipid microdomains 
are relatively stable as they are resistant to several non-ionic detergents. This unique biophysical 
property differentiates lipid rats from other membrane parts. Since the other phospholipids are 
relative fluid, these lipid microdomains seem to float in the ocean of phospholipids and thereby 
they were termed lipid rafts. Due to this unique biophysical property, lipid rafts show high affinity 
for certain proteins such as glycophosphatidylinositol (GPI)-anchored proteins, cholesterol-linked 
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proteins and some transmembrane proteins or receptors. (Nature Reviews Immunology 2; 96-105, 
2002) 
1.1.2 Synthesis, metabolism and signaling of ceramide 
Ceramide is generated by several enzymatic pathways in mammalian cells. Two major 
pathways are the sphingomyelinase pathway that ceramide generates from sphingomyelin 
by the activities of sphingomyelinases and the de novo synthesis pathway that synthesizes 
ceramide from serine and palmitoyl-CoA by the activity of ceramide synthase. 
Sphingomyelinases belong to the family of sphingomyelin-specific phospholipase C (PLC), 
which hydrolyzes sphingomyelin to ceramide and phosphorylcholine. Sphingomyelin can 
be regenerated from ceramide by sphingomyelin synthase. Ceramide can also be converted 
into other sphingolipids, such as ceramide-1-phosphate, sphingosine, and sphingosine-1-
phosphate (Figure 1.2). Recent studies further revealed three additional pathways for the 
formation of ceramide, i.e. by the reverse activity of the acid ceramidase catalyzing 
synthesis of ceramide from sphingosine (Okino et al., 2003), by hydrolysis of complex-
glycosylated lipids (Ishibashi et al., 2007) and by hydrolysis of ceramide-1-phosphate 
(Mitra et al., 2007). 
 
At least five types of sphingomyelinase have been described. These enzymes are (1) the 
lysosomal acid sphingomyelinase, (2) the Zn2+-dependent acid sphingomyelinase, (3) the 
membrane-bound magnesium-dependent neutral sphingomyelinase, (4) the magnesium-
independent neutral sphingomyelinase, and (5) the alkaline sphingomyelinase. With 
respect to cell signaling, acid sphingomyelinase and neutral sphingomyelinase are 
considered the two major sphingomyelinases. They can be activated by growth factors, 
cytokines, chemotherapeutic agents, irradiation, nutrient removal, and stress to produce 
ceramide and other downstream sphingolipids and therefore they are involved in the 
regulation of cell growth, differentiation, cell cycle arrest, and apoptosis. 
 
The de novo synthesis of ceramide begins with the condensation of serine and palmitoyl-
CoA by serine palmitoyl-transferase, which forms 3-ketosphingosine, which then 
undergoes reduction to dihydrosphingosine. By addition of a C16 to C24 fatty acid to the 
amino group of dihydrosphingosine via ceramide synthase, dihydroceramide is produced, 
which is immediatedly converted to ceramide by the introduction of a trans double bond 
between carbons 4 and 5 of the sphingoid base. Originally, this de novo synthesis was not 
considered as an important signaling pathway since the synthesis reaction is relatively slow 
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compared to the sphingomyelin pathway. However, recent studies have demonstrated that 
the de novo synthesis occurs also rapidly when cells are exposed to many stimuli (Chalfant 
et al., 2002; Wang et al., 2002; Seumois et al., 2007). Therefore, the de novo synthesis is 
currently classified as a signaling enzymatic pathway.  
 
Ceramide-mediated transmembrane and intracellular signaling has been demonstrated in a 
variety of mammalian cells. There is general agreement that sphingomyelin and its 
metabolites constitute a novel ubiquitous and evolutionarily conserved signaling pathway 
similar to the phosphoinositide and diacylglycerol (DAG) systems, where ceramide serves 
as an important mediator to regulate a number of cellular functions or activities. It has been 
suggested that ceramide, once generated, may directly or indirectly regulate the activity of 
various signaling components including ceramide-activated protein kinase (CAPK), 
ceramide-activated protein phosphatase (CAPP), sphingolipid-sensitive Ca2+ channels, and 
protein kinase C. However, the mechanisms responsible for the action of ceramide on these 
downstream targets are not fully understood.   
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Figure 1.2 Ceramide synthesis and metabolism. 
Ceramide can be generated from the sphingomyelin via sphingomyelinase pathway (sphingomyelin 
metabolism) or via the de novo synthesis pathway where cells synthesize ceramide from serine and 
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palmitoyl-CoA (de novo synthesis). Ceramide can be further converted into other sphingolipids 
such as ceramide-1-phosphate, sphingosine and sphingosine-1-phosphate. 
 
1.1.3 Acid sphingomyelinase and ceramide-enriched membrane domains 
Acid sphingomyelinase is the first and best-characterized sphingomyelinase and the 
enzyme was shown to be critically involved in many forms of cell activation (Samet and 
Barenholz, 1999; Gulbins and Kolesnick, 2003). Acid sphingomyelinase hydrolyzes 
sphingomyelin to ceramide, preferentially at an acidic pH. However, because other lipids 
crucially influence the Michaelis-Menten constant (Km) of the enzyme to its substrate, the 
enzyme seems to be able to hydrolyze sphingomyelin also under almost neutral conditions 
(Schissel et al., 1996 and 1998).  
 
The acid sphingomyelinase exists in two forms, a lysosomal acid sphingomyelinase and a 
secretory acid sphingomyelinase that are both derived from the same gene, but differ in 
their glycosylation pattern and are also differentially processed at the NH2-terminus 
(Schissel et al., 1998). Most of acid sphingomyelinase seems to reside in classic lysosomes, 
where it mediates the catabolism of sphingomyelin. A genetic defect in acid 
sphingomyelinase leads to the accumulation of sphingomyelin and a lysosomal storage 
disorder named Niemann-Pick disease type A and B. The pool of acid sphingomyelinase 
insecretory lysosomes seems to participate in signal transduction events (Schissel et al., 
1996 and 1998; Grassmé et al., 2001a; Herz et al., 2009; Bao et al., 2010). Mobilization of 
these vesicles triggers the fusion of secretory lysosomes and the cell membrane, and this 
fusion results in the exposure of acid sphingomyelinase on the outer leaflet of the cell 
membrane (Herz et al., 2009; Bao et al., 2010).  
 
Activation of several receptors, such as CD95, DR5, CD40, and the platelet-activating 
factor (PAF) receptor, but also some bacterial and viral infections or stress stimuli, trigger 
the surface exposure of acid sphingomyelinase (Grassmé et al., 2001a; Cremesti et al., 
2001). Further, changes in the glycosylation pattern of acid sphingomyelinase result in the 
expression of a secretory form of acid sphingomyelinase that is released upon stimulation, 
for instance by activation of interleukin-1 receptors (Schissel et al., 1996 and 1998).  
 
Acid sphingomyelinase and secretory acid sphingomyelinase hydrolyze sphingomyelin 
from membrane and generate ceramide within cell membranes. The release of ceramide 
within the cell membrane alters the biophysical characteristics of membranes, because they 
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spontaneously self-associate to small, highly dydrophobic, and ordered ceramide-enriched 
membrane microdomains, which tend to fuse spontaneously to larger ceramide-enriched 
membrane platforms. Ceramide-enriched membrane domains seem to be tightly packed 
and, thus, rather stabile membrane domains, consistent with the observation that ceramide 
promotes the formation of membrane domains into a liquid ordered state (Megha and 
London, 2004; Veiga et al., 1999).  
 
 
Figure 1.3 CD95 stimulation induces ceramide-enriched membrane platforms. 
Stimulation of Jurkat T-lymphocytes via CD95 results in the formation of ceramide-enriched 
membrane platforms on the cell surface. Cells were stimulated, fixed, stained with Cy3-coupled 
anti-ceramide antibodies and analyzed by confocal microscopy. (Grassmé et al., J. Biol. Chem, 
2001a) 
 
Ceramide-enriched membrane domains were demonstrated in living cells by fluorescence 
microscopy (Figure 1.3) (Grassmé et al., 2001a). Studies on phosphatidylcholine 
/sphingomyelin-composed unilamellar vesicle that were treated with sphingomyelinase 
immobilized onto a microbead confirmed the formation of ceramide-enriched membrane 
macrodomains (Nurminen et al., 2002). The formation of distinct membrane domains by 
ceramide is also indicated by magnetic resonance spectroscopy and atomic force 
microscopy studies that revealed laminar phase separation of long chain ceramides in 
glycerophospholipid/cholesterol bilayers and formation of stable, distinct domains that 
correspond with a transition of fluid phospholipid bilayers into a gel-like phase (Veiga et 
al., 1999; Huang et al., 1999). Finally, biophysical studies demonstrated that small amounts 
of ceramide significantly increased the gel-to-fluid transition temperature of 
sphingomyelin suggesting the formation and stabilization of a liquid ordered state (Huang 
et al., 1999). 
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1.1.4 Function of ceramide-enriched membrane platforms and receptor clustering 
Many diverse receptors and stimuli trigger the release of ceramide and the formation of 
ceramide-enriched membrane domains, including CD95 (Grassme et al., 2001a and 2003; 
Cremesti et al., 2001), CD40 (Grassme et al., 2002), DR5 (Dumitru et al., 2006), FcγRII 
(Abdel Shakor et al., 2004), the PAF-receptor (Goggel et al., 2004), CD14 (Pfeiffer et al., 
2001), infection with P. aeruginosa (Grassme et al., 2003), S. aureus (Esen et al., 2001), N. 
gonorrhoeae (Grassme et al., 1997; Hauck et al., 2000), Rhinovirus (Grassme et al., 2005), 
application of stress stimuli such as γ-irradiation (Santana et al., 1996), UV-light 
(Charruyer et al., 2005) and in some conditions of developmental death. 
Ceramide-enriched membrane domains are perfect structures to sort proteins in cells and to 
provide a mean for the spatial re-organization of receptors and intracellular signalling 
molecules upon cellular stimulation. Ceramide-enriched membrane platforms were shown 
to trap and, thus, cluster receptor molecules (Grassmé et al., 2001a and 2003; Nurminen et 
al., 2002; Cremesti et al., 2001). Clustering of receptor molecules results in a very high 
receptor density within a small area of the cell membrane, a phenomenon that is required 
for the transmission of signals via many receptor molecules. Receptor aggregation and 
trapping in ceramide-enriched membrane domains may limit lateral diffusion and, thus, 
stabilize the interaction of a ligand with its receptor, in particular if the ligand is also 
trapped in distinct membrane domains. The interaction of ligand-bound receptors with the 
very hydrophobic ceramide-enriched membrane platform and/or individual ceramide 
molecules may in addition stabilize conformational changes that may occur upon 
activation of a receptor by its ligand. Clustering of receptors also results in clustering of 
receptor-associated signalling molecules within or at ceramide-enriched domains. 
Furthermore, ceramide-enriched membrane domains, although present in the outer leaflet 
of the cell membrane, may sort intracellular signalling molecules, for instance via farnesyl- 
or geranyl-moieties. This sorting function may result in the spatial association of activated 
receptors with signalling molecules that transmit the signal from the receptor into the cell, 
while at the same time inhibitory molecules are excluded from this area of the cells. In 
addition, a high concentration and close vicinity of enzymes may permit enhanced 
transactivation of enzymes associating with the activated receptor, for instance of caspases 
associating with death receptor.  
Thus, these considerations suggest that ceramide-enriched membrane platforms have a 
general function in signal transduction, i.e. they may primarily function to spatially 
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organize receptors and the intracellular signalosome in and at the cell membrane to 
facilitate and amplify signaling processes. The amplification function of ceramide-enriched 
membrane platforms has been demonstrated for CD95 signaling on B-lymphocytes lacking 
functional acid sphingomyelinase expression (Grassmé et al., 2001a and 2003). These cells 
fail to release ceramide upon CD95 stimulation. Binding of CD95 ligands to CD95 only 
resulted in a very weak activation in these cells as indicated by levels of recruitment of 
FADD and stimulation of caspase 8 that only reached approximately 1% of the levels 
achieved after maximal activation of CD95 in wild type, acid sphingomyelinase-positive 
cells. These studies demonstrate that ceramide-enriched membrane platforms serve to 
cluster activated receptor molecules and provide a feed-forward mechanism resulting in 
recruitment of signaling molecules and marked amplification of a primary weak signal. 
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1.2 Redox signaling  
1.2.1 Reactive oxygen species (ROS) 
Redox signaling is a fundamental signaling mechanism in cell biology. Various ROS, 
including O2.–, H2O2, .OH, and ONOO.–, participate in cell signaling under certain 
physiological or pathological conditions. The most important of these ROS is O2.–, which 
is unstable and short-lived because it has an unpaired electron, and it is highly reactive 
with a variety of cellular molecules, including proteins and DNA. O2.– is reduced to H2O2 
by superoxide dismutase (SOD), and both O2.– and H2O2 can diffuse from their sites of 
generation to other cellular locations. H2O2 is further reduced to generate the highly 
reactive .OH through the Haber-Weiss or Fenton reaction under pathological conditions. In 
contrast to O2.– and H2O2, .OH is highly reactive and, therefore, causes primarily local 
damage. In addition, O2.– can also interact with NO to form another reactive oxygen free 
radical, ONOO.–. Under physiological conditions, O2– preferably produces H2O2 via the 
dismutation reaction. However, when excess O2.– is produced, a substantial amount of O2.– 
reacts with NO to produce ONOO.–. Taken together, these ROS constitute a redox 
regulatory network that controls cellular activity and function. Unbalanced or enhanced 
production of ROS impaired function of the antioxidant system, or both result in oxidative 
stress. 
 
O2.– has been considered the progenitor of other ROS. In mammalian cells, many pathways 
are involved in the production of O2.–, including nicotinamide adenine dinucleotide 
phosphate (NADPH) oxidase, xanthine oxidase, mitochondrial respiration chain, and NO 
synthase-uncoupling. NADPH oxidase has been detected in nearly every tissue, and in 
many cells, such as those in the phagocytes and vascular cells, it is the primary source of 
ROS. Recent studies suggest that NADPH oxidase localizes to specific subcellular 
compartments, including lamellipodial focal complexes and focal adhesions, membrane 
ruffles, caveolae and lipid rafts, endosomes, sarcoplasmic reticulum, and the nucleus. NO 
synthases normally localize in caveolae and function as homodimers to synthesize NO. 
When exposed to oxidative or nitrosative stress, NOS becomes structurally unstable 
(“uncoupling state”) and exhibits NADPH oxidase activity resulting in O2.– formation. 
Given that ROS are short-lived and diffusible, the localization of ROS signals in specific 
subcellular compartments suggests that mammalian cells contain temporally and spatially 
organized redox signaling pathways that regulate various cellular functions.  
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1.2.2 NADPH oxidase 
NADPH oxidase, identified and characterized first in neutrophils, catalyzes the 1-electron 
reduction of oxygen producing O2.- using NADPH as the electron donor. This neutrophil 
oxidase consists of at least five subunits: two membrane-bound subunits gp91phox and 
p22phox and three cytosolic subunits p47phox, p40phox and p67phox. gp91phox and p22phox form 
an integral membrane complex termed cytochrome b558, and the other three subunits, 
p47phox, p67phox, and p40phox localize in the cytosol in resting cells. Upon stimulation, these 
cytosolic subunits translocate to the cell membrane and bind to cytochrome b558 to 
function as an oxidase. In addition, a cytosolic GTPase, Rac importantly participates in the 
activation of NADPH oxidase by assembling the NADPH oxidase complexes in the 
membrane. (Figure 1.4) 
 
To date, several homolog proteins of gp91phox were discovered in nonphagocytic cells and 
termed Nox (for NADPH oxidase) proteins. There are five Nox isoforms identified, 
namely Nox1-5, among which Nox2 is gp91phox. Noxs are encoded by separate individual 
genes. gp91phox or Nox2 is highly abundant in phagocytes and is the major enzyme 
responsible for respiratory burst of ROS upon bacterial infection, a key event in the 
defense against pathogenic bacteria.  
 
p67phoxRac
p47phox
gp91phox
p22phox
p40phox
extracellular
Membrane
intracellular
p22phox
extracellular
Membrane
intracellularp47phox
p67phox
Rac
p40
phox
P
PNADPH
NADP+
gp91phox
2O2.-
2O2
• • H+
 
Figure 1.4 Phagocytic NADPH oxidase mediated electron transfer and O2.- production.  
Upon stimulation, p47phox is phosphorylated and translocates to the membrane. NADPH oxidase 
subunits aggregate in the membrane to form a functional enzyme. gp91phox uses NADPH as 
substrate to transfer two electrons to molecular oxygen on the opposite side of the membrane to 
produce O2.-. 
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1.3 Cystic fibrosis and pulmonary Pseudomonas aeruginosa (P. 
aeruginosa) infections 
1.3.1 Cystic fibrosis 
Cystic fibrosis is caused by mutations of the Cystic Fibrosis Transmembrane Conductance 
Regulator (CFTR) and constitutes with 1 case per 2500 births the most common autosomal 
recessive disorder in the EU and the USA (Kerem et al., 1989; Rommens et al., 1989; 
Riordan et al., 1989). Approximately 40 000 children and young adults are affected in the 
EU.  
 
Many mutations in the CFTR gene have been found to induce cystic fibrosis, however, the 
mutations that cause most clinical cases are those of amino acids 508 and 551 (Kerem et al., 
1989; Rommens et al., 1989; Riordan et al., 1989). Genetic defects in the CFTR molecule 
result in several clinical symptoms, the most common of which are pulmonary and 
gastrointestinal problems. Gastrointestinal symptoms include malabsorption, intestinal 
obstruction, defects in the secretion of pancreatic enzymes, pancreatitis, and alterations in 
the liver. Pulmonary symptoms are mucus plugging and chronic bacterial infection, 
accompanied by a pronounced inflammatory response; damage the airways, ultimately 
leading to bronchiectasis and respiratory insufficiency. In particular cystic fibrosis patients 
suffer recurrent and chronic infections with P. aeruginosa and Burkholderia cepacia, but 
also Staphylococcus aureus and Haemophilus influenzae. At present, the pulmonary 
problems are most important for the disease course and for patients’ life expectancy. 
However, the cause for the high sensitivity of cystic fibrosis patients to develop these 
pulmonary infections is unknown. 
 
1.3.2 Pulmonary P. aeruginosa infections  
P. aeruginosa is a Gram-negative, aerobic, rod-shaped bacterium with unipolar motility. It 
is an environmental pathogen found in moist areas such as sinks and drains. P. aeruginosa 
infections are most important in patients with cystic fibrosis, immunosuppression, 
ventilation, lung wounds. Once past early childhood a very high percentage of patients 
with cystic fibrosis suffer from recurrent and finally chronic P. aeruginosa pneumonia. 
More than 80% of adult cystic fibrosis patients are infected with the pathogen and chronic 
P. aeruginosa lung infections are the leading cause of morbidity and mortality in cystic 
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fibrosis. Smaller numbers of cystic fibrosis patients will become infected with other 
organisms such as S. maltophilia, B. cepacia and non-tuberculous mycobacteria, some of 
which appear to be increasing in prevalence.  
In the healthy host bacteria entering the lungs are cleared rapidly, without the initiation of 
an inflammatory response, by a variety of innate host defense strategies, both mechanical 
(mucocilary clearance) and immunological (resident macrophages and anti-microbial 
peptides). In certain clinical situations, this first line of defense fails and these normally 
harmless bacteria survive, multiply and lead to organ damage. Such situations include 
mechanically ventilated patients in intensive care, those with defective immunity or severe 
burns and patients with cystic fibrosis.  
 
1.3.3 Mechanisms involved in development of cystic fibrosis 
The hallmarks of cystic fibrosis lung disease are early and persistent infection with a 
relatively narrow range of bacteria and severe and sustained neutrophil-mediated 
inflammation. The exact role of CFTR dysfunction in the sequence of events leading to 
chronic airway infection and irreversible damage is controversial and incompletely 
understood. However, it is presumed that bacterial adherence (either to airway secretions 
or directly to the cell surface) and resistance to innate defenses are key factors. Many 
studies have demonstrated that the development of this disease is very complex. Several 
explanations have been postulated, including (1) impairments in the mucociliary system 
and impaired function of anti-microbial peptides, (2) alterations in the mucus that lines the 
respiratory tract, (3) defective ingestion of bacteria by epithelial cells lacking CFTR, (4) 
alterations in the frequency of cell death induced in mammalian cells by pathogens, (5) 
alterations in the function of neutrophils and macrophages, (6) and low levels of defence 
molecules such as nitric oxide and glutathione and (7) changes in lipid metabolism. The 
relative importance of certain of these mechanisms in vivo has not yet been determined.  
 
Because CFTR exhibits chloride channel activity, researchers speculated that the changes 
in water absorption by the mucus found on epithelial cells of the respiratory tract, which 
finally may result in a reduced mucociliary clearance and a reduced ability to eliminate P. 
aeruginosa (Matsui et al., 2005; Boucher, 2007). The increased viscosity of the mucus may 
also affect the ability of neutrophils to migrate to and kill bacteria in the respiratory tract. 
However, although in vitro experiments suggested the concept of reduced mucociliary 
clearance in cystic fibrosis (Matsui et al., 2005), in vivo studies on cystic fibrosis patients 
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failed to demonstrate a significant and uniform reduction of the mucociliary clearance in 
these individuals (Boucher, 2007).  
 
A defect in the chloride channel function of CFTR may also result in changes of the ion 
concentration in the mucus. The altered concentration of ions may then impair the function 
of defensins and other anti-microbial peptides and, thus, reduce the elimination of P. 
aeruginosa in the lung (Goldman et al., 1997). However, at present it is unknown whether 
the defect of CFTR really results in hypertonic salt concentrations on the respiratory 
epithelium in vivo and, thus, dysfunction of antimicrobial peptides.  
 
Pier et al. demonstrated a defect of the innate immune function of epithelial cells in the 
respiratory tract of cystic fibrosis mice. They showed that the lipopolysaccharide (LPS)-
molecule of P. aeruginosa binds to a short amino acid sequence in CFTR (AA 103-117) 
(Pier et al., 1996). This interaction mediates internalisation of P. aeruginosa into lung 
epithelial cells. Deficiency of Cftr or blockade of the binding sequence prevents P. 
aeruginosa internalisation (Pier et al., 1996). Bacterial internalisation correlates with the 
defence against P. aeruginosa in lungs of infected mice, although the causative role of the 
internalisation defect for the high sensitivity of these mice to develop P. aeruginosa 
infections remains to be demonstrated. Further studies suggested that internalisation of P. 
aeruginosa is also mediated by other mechanisms. The uptake mechanisms also seem to 
depend on the bacterial strain, since rough, mucoid strains of P. aeruginosa are able to 
enter epithelial cells independent of CFTR expression (Schroeder et al., 2001).  
 
Studies by several groups demonstrate that P. aeruginosa triggers cell death of Cftr-
positive epithelial cells in vitro as well as in a focal pattern in bronchial epithelial cells in 
the lung. Apoptosis is mediated by an activation of the endogenous CD95 receptor/CD95 
ligand-system within distinct membrane domains in epithelial cells upon infection with P. 
aeruginosa (Grassme et al., 2000; Jendrossek et al., 2001 and 2003; Kowalski et al., 2004; 
Grassme et al., 2003). In vivo studies indicate that stimulation of CD95 and, thus, 
presumably induction of apoptosis in epithelial cells is central for a coordinated defense 
against pulmonary P. aeruginosa infections. It might be possible that the induction of 
apoptosis in epithelial cells modulates the local immune response to the pathogen and 
prevents an over-shooting release of cytokines (Grassmé et al., 2003). In contrast, 
induction of apoptosis of epithelial cells by P. aeruginosa is abrogated in Cftr-deficient 
cells, which might contribute to inflammation and infection susceptibility (Grassmé et al., 
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2003). Studies from Kumar et al. on two independent cystic fibrosis patient cohorts 
demonstrate that allelic variants within intron 2 of the CD95 gene modulate the 
manifestation of cystic fibrosis disease further suggesting a role of CD95-mediated 
signalling/apoptosis in cystic fibrosis (Kumar et al., 2008).  
 
Several studies in the recent years suggest an imbalance between pro-inflammatory and 
anti-inflammatory cytokines in the airways of cystic fibrosis patients as one of the leading 
causes to result in destruction of the lung and the high susceptibility of these patients to 
infections with P. aeruginosa. It was demonstrated that cells lacking functional CFTR 
secrete increased amounts of Interleukin (IL)-1, IL-8/KC, TNF-alpha and Mip-2 upon 
infection with P. aeruginosa compared to control cells (Tirouvanziam et al., 2000; Inoue et 
al., 1994; Oceandy et al., 2002; Bonfield et al., 1995). IL-8 is already increased in the 
trachea of non-infected Cftr-deficient mice (Inoue et al., 1994), while the synthesis of anti-
inflammatory cytokines, in particular IL-10 (Bonfield et al., 1995), has been shown to be 
reduced in Cftr-deficient mice under basal conditions as well as after infection with P. 
aeruginosa. The increased release of pro-inflammatory cytokines from CFTR-deficient 
epithelial cells correlates with a constitutive activation of NFκB in these cells 
(Venkatakrishman et al., 2000). However, at present, the mechanisms how a defect in 
CFTR results in an increased NFκB-activity, an enhanced release of pro-inflammatory 
cytokines and a decreased formation of anti-inflammatory cytokines are unknown.  
 
1.3.4 Ceramide in cystic fibrosis 
Recent studies highlight a critical role of ceramide in the development of cystic fibrosis 
and the high sensitivity of Cftr-deficient mice to P. aeruginosa infections (Teichgräber et 
al., 2008; Brodlie et al., 2010). Teichgräber and co-workers showed an accumulation of 
ceramide in lungs of different Cftr-deficient mouse strains (Teichgräber et al., 2008). This 
increase of ceramide was also observed in the lower airway epithelium of people with 
advanced cystic fibrosis (Brodlie et al., 2010). Teichgräber found ceramide particularly 
accumulates in epithelial cells of large and small bronchi in different Cftr-deficient mouse 
strains. Of note, ceramide accumulates in these cells prior to any infection. Further, 
ceramide accumulates in the lungs of Cftr-deficient mice in an age-dependent manner, 
which seems to mimic the delayed onset of symptoms in humans. The accumulation of 
ceramide in Cftr-deficient cells has been attributed to an alteration of the pH particular in 
secretory lysosomes, prelysosomes and/or lysosomes. Since the signaling pool of the acid 
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sphingomyelinase seems to be predominantly localized to secretory lysosomes, a primary 
accumulation of ceramide may occur within these vesicles. Since the enzymes that control 
ceramide metabolism in acidic vesicles are pH-dependent, an alkalinization of these 
vesicles has a dramatic effect on ceramide concentrations; sphingomyelin is constitutively 
metabolized to ceramide by the acid sphingomyelinase and consumed to sphingosine by 
the activity of the acid ceramidase. An increase of the pH from values around 4.5 to pH 6.0 
reduces the activity of the acid sphingomyelinase by only ~30%, while the acid ceramidase 
is almost inactived at pH 6.0. The imbalance of the two enzymes activities with a relative 
over-activity of the acid sphingomyelinase may then result in an accumulation of ceramide. 
Increased ceramide concentrations in bronchial epithelial cells and lung macrophages of 
Cftr-deficient mice trigger several hallmarks of cystic fibrosis, i.e. death of respiratory 
epithelial cells and deposition of DNA in bronchi, chronic pulmonary inflammation and 
high susceptibility of Cftr-deficient mice to develop pulmonary P. aeruginosa infections 
(Teichgräber et al., 2008). In this respect, inhalation of inhibitors of the acid 
sphingomyelinase reduces DNA-deposits in lungs of cystic fibrosis mice and prevents 
infection with P. aeruginosa (Becker et al., 2009). 
 
Recent study also demonstrated a defective activation of acid sphingomyelinase pathway 
upon P. aeruginosa infection in both a cystic fibrosis bronchial epithelial cell line and in 
the lungs of Cftr-deficient mice as compared with control epithelial cells and wild-type 
mice (Yu et al., 2009). Acid sphingomyelinase activity and total ceramide levels 
significantly increased in control epithelial cells and wild-type mice upon P. aeruginosa 
infection, but not in Cftr-deficient cells and mice. This defective acid sphingomyelinase 
pathway in cystic fibrosis may be attributing to alkalinization of the vesicles containing 
signaling acid sphingomyelinase. 
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1.4 Aims of the study 
As described above, recent studies using human subjects and animal studies using Cftr-
deficient mice highlight a role of ceramide in the development of this inherited disease 
(Teichgräber et al., 2008; Becker et al., 2009; Yu et al., 2009; Brodlie et al., 2010). 
Particularly, our group has demonstrated that alteration in ceramide metabolism 
contributes to the pathological development of cystic fibrosis. Age-dependent 
accumulation of ceramide was detected in the epithelium of the lungs of Cftr-deficient 
mice. However, it is unknown whether ceramide is also altered in other lung cells. 
Alveolar macrophages serve as the first line of host defense to clear extracellular bacteria 
from the lung. These lung resident macrophages are critically involved in coordinating the 
innate immune response during the bacterial infection. At present, the role of alveolar 
macrophage in cystic fibrosis is not well understood.  
 
The present thesis first defines the role of ceramide-mediated signaling in regulating 
functions of lung alveolar macrophages during pulmonary P. aeruginosa infections. 
Because ceramide is an important signaling molecule that regulates redox signaling (Zhang 
et al., 2007), the present study will investigate whether P. aeruginosa infections result in 
activation of acid sphingomyelinase, formation of ceramide-enriched membrane platforms 
and clustering of NADPH oxidase in the plasma membrane. The importance of acid 
sphingomyelinase and ceramide platforms for NADPH oxidase-derived ROS production 
will be tested by using Acid sphingomyelinase-deficient cells. 
 
The second part of the study addresses whether Cftr-deficiency results in alterations of 
ceramide metabolism and ceramide-mediated redox signaling in lung alveolar 
macrophages. Because CFTR increases pH in at least some intracellular vesicles such as 
lysosomes by its action to mediate the influx of counterions into intracellular vesicles 
(Barasch et al., 1991; Poschet et al., 2002; Di et al., 2006; Teichgräber et al., 2008; Deriy 
et al., 2009). It will be tested whether Cftr-deficiency causes defects in lysosomal 
acidification, acid sphingomyelinase/ceramide-mediated amplification of redox signaling 
and killing invaded P. aeruginosa by these lung macrophages.  
 
Our results will increase the understanding of the signaling mechanisms that cause defects 
in innate responses of cystic fibrosis lungs and the high susceptibility to P. aeruginosa 
infections.   
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2. MATERIALS 
 Chemicals 
Aqua ad Injectabilia 
 
DeltaSelect GmbH, Dreieich 
Acetic acid (C2H4O2)  Merck, Darmstadt 
 
Adenosine Tri-Phosphate (ATP)  Sigma-Aldrich Chemie GmbH, Steinheim 
 
Apocynin 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
 
Bafilomycin 
 
Sigma, Deisenhofen, Germany 
β-mercaptoethanol 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
 
Bromphenol blue 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
 
C16-Ceramide Biomol, PA, USA 
 
Calcium chloride (CaCl2)  Sigma-Aldrich Chemie GmbH, Steinheim 
 
Cardiolipin Sigma-Aldrich Chemie GmbH, Steinheim 
 
Chloroform (CHCl3)  Ridel-de Haen, Seelze 
 
Diethylenetriaminepentaacetic Acid 
(DETAPAC)  
Sigma-Aldrich Chemie GmbH, Steinheim 
 
 
Dithiothreitol (DTT)  Carl-Roth GmbH & Co, Karlsruhe 
 
Ethidium bromide 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
 
Ethylenediamine Tetraacetic Acid  
(EDTA) 
 
Serva Electrophoresis GmbH, Heidelberg 
 
FACS buffer 
 
BD Biosciences, Heidelberg, Germany 
 
Glucose Sigma-Aldrich Chemie GmbH, Steinheim 
 
Glycerol Fluka Chemie GmbH, Buchs 
 
H2DCFDA 
 
Molecular Probes, Eugene, OR 
Hepes Carl-Roth GmbH & Co, Karlsruhe 
 
Hydrochloric acid (HCl) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Imidazole (C3H4N2) Sigma-Aldrich Chemie GmbH, Steinheim 
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Ionophore nigericin 
 
Invitrogen, Karlsruhe, Germany 
Isopropanol 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
 
Ketamine 
 
Ceva Tiergesundheit GmbH, Duesseldorf 
Magnesium chloride (MgCl2) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Magnesium sulphate (MgSO4) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Methanol (CH3OH) Fluka Chemie GmbH, Buchs 
 
Mowiol Kuraray Specialities Europe GmbH, Frankfurt 
 
MTT 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
 
N-octylglucopyranoside Sigma-Aldrich Chemie GmbH, Steinheim 
 
Paraformaldehide (PFA) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Phosphatase inhibitor Sigma-Aldrich Chemie GmbH, Steinheim 
 
Potassium chloride (KCl) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Potassium dihydrogenphosphate 
(KH2PO4) 
 
Sigma-Aldrich Chemie GmbH, Steinheim 
Protease inhibitor Carl-Roth GmbH & Co, Karlsruhe  
 
RPMI-1640 Gibco/Invitrogen, Karlsruhe, Germany 
 
Saponin 
 
Serva Electrophoresis GmbH, Heidelberg 
 
Sodium acetate (CH3COONa) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Sodium chloride (NaCl) Carl-Roth GmbH & Co, Karlsruhe  
 
Sodium dodecyl sulphate (SDS) Serva Electrophoresis GmbH, Heidelberg 
 
Sodium hydroxide (NaOH) Sigma-Aldrich Chemie GmbH, Steinheim 
 
Sodium phosphate (Na2HPO4) Merck, Darmstadt 
 
Taq Polymerase 
 
Invitrogen, Karlsruhe, Germany 
Tryptic soy broth (TSB) 
 
BD Biosciences, Heidelberg, Germany 
 
Tris Carl-Roth GmbH & Co, Karlsruhe 
 
Triton X-100 Sigma-Aldrich Chemie GmbH, Steinheim 
 
Xylazin Ceva Tiergesundheit GmbH, Duesseldorf 
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 Antibodies, dye and ELISA kit 
Alkaline phosphatase-coupled 
secondary antibodies 
 
Santa Cruz Biotechnology, CA, USA  
Anti-ceramide (clone 15B4) 
Mouse IgM 
 
Glyobiotech, Kükels, Germany 
 
Anti-gp91phox  
Mouse IgG 
 
BD Biosciences, Heidelberg, Germany 
 
Anti-JNK1 
Rabbit IgG 
 
Santa Cruz Biotechnology, CA, USA  
Anti-phospho-c-Jun  
Rabbit IgG 
 
Cell signaling, Danvers, MA, USA 
 
Anti-phospho-JNK 
Rabbit IgG 
 
Cell signaling, Danvers, MA, USA 
 
Cy3-anti-rabbit IgG 
 
Jackson Immunoresearch, West Grove, PA, 
USA 
Cy3-goat anti-mouse IgM 
 
Jackson ImmunoResearch Laboratories 
Cy5-anti-mouse IgM F(ab’)2 
 
Jackson Immunoresearch, West Grove, PA, 
USA 
 
FITC-goat anti-mouse IgG 
 
Jackson Immunoresearch, West Grove, PA, 
USA 
 
KC ELISA kit 
 
R&D Systems, Wiesbaden-Nordenstadt, 
Germany  
 
LysoSensor Green DND-189 
 
Molecular Probes, Invitrogen, Karlsruhe, 
Germany 
 
LysoSensor Green DND-153 
 
Molecular Probes, Invitrogen, Karlsruhe, 
Germany 
 
MIP-2 ELISA kit 
 
R&D Systems, Wiesbaden-Nordenstadt, 
Germany 
 
TMR-dextran 
 
Molecular Probes, Invitrogen, Karlsruhe, 
Germany 
 
 PCR primers 
ASM-PA 1-2 Hermann GbR, Freiburg 
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5´-CGA GAC TGT TGC CAG ACA TC-3´  
 
ASM-PA 2-2 
5´-GGC TAC CCG TGA TAT TGC TG-3´ 
Hermann GbR, Freiburg 
 
 
ASM-PS-2 
5´-AGC CGT GTC CTC TTC CTT AC-3´ 
Hermann GbR, Freiburg 
 
 
Myco P1 
5´-GTG CCA GCA GCC GCG GTA ATA C-3´ 
Hermann GbR, Freiburg 
 
 
Myco P4 
5´-TAC CTT GTT ACG ACT TCA CCC CA-3´ 
Hermann GbR, Freiburg 
 
 
IMR1125 
5’-GAG AAC TGG AAG CTT CAG AGG-3’ 
Hermann GbR, Freiburg 
 
IMR1126 
5’-TCC ATC TTG TTC AAT GGC C-3’ 
Hermann GbR, Freiburg 
 
IMR1127 
5’-TCC ATG TAG TGG TGT GAA CG-3’ 
 
Hermann GbR, Freiburg 
 
3473f 
5’-CTC GTG CTT TAC GGT ATC GCC-3’ 
 
Hermann GbR, Freiburg 
 
3473r 
5’-TGC TGT AGT TGG CAA GCT TTG A-3’ 
 
Hermann GbR, Freiburg 
 
5012f 
5’-CCT TCC ATG TAC CCC TCC TCA CTT-3’ 
 
Hermann GbR, Freiburg 
 
5012r 
5’-CCC GGC ATA ATC CAA GAA AAT TG-3’ 
 
Hermann GbR, Freiburg 
 
 
 Animals 
Acid sphingomyelinase-deficient (sphingomyelin phosphodiesterase 1 (Smpd1–/–) knockout) 
mice (on a C57Bl/6 background) were kindly provided by Dr. R. Kolesnick (Memorial 
Sloan-Kettering Cancer Center, NY, USA). Syngenic wild-type mice from the same 
heterozygous breeding were used as control. The mice used in the present study show the 
earliest clinical manifestation of Niemann-Pick disease type A between 12-16 weeks of age; 
therefore, all the experiments involving cells from acid sphingomyelinase-deficient mice 
were carried out with animals younger than 12 weeks of age, before any biochemical, 
histological or clinical manifestations of Niemann-Pick disease type A were apparent. This 
excluded that the effects observed in the acid sphingomyelinase-deficient cells were due to 
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altered cellular processes but instead, were completely dependent on the lack of acid 
sphingomyelinase. 
 
 Two mouse strains of Cftr-deficient mice were used, one is B6.129P2(CF/3)-
CftrTgH(neoim)Hgu (abbreviated CftrMHH, syngenic to C57BL/6; kindly provided by Dr. B. 
Tümmler, Medizinische Hochschule Hannover) and the other is strain Cftrtm1Unc-
Tg(FABPCFTR) (abbreviated CftrKO; obtained from Jackson Laboratory, Bar Harbor, ME). 
Neither of these Cftr-deficient mouse strains requires a special diet. This characteristic is 
important because some diets have been shown to alter membrane lipid composition 
(Borowitz et al., 2005; Cottart et al., 2007; Teichgraber et al., 2008; Becker et al., 2009). 
Changes in lipid composition, in particular an alteration in cholesterol and sphingolipids 
concentrations, may regulate the activity of ion channels and pumps (Schreur and Liu, 
1997; Gulbins et al., 1997; Lepple-Wienhues et al., 1999). Littermates of the C57BL/6 
mice were used as control animals.  
 
Wild-type and Asm-deficient or Cftr-deficient mice were propagated in the Animal Facility 
of the Uniklinikum Essen. Homozygocity of wild-type and Asm- or Cftr-deficient mice 
were propagated in the Animal Facility of the Uniklinikum Essen. Homozygocity of WT 
and Asm- or Cftr-deficient mice was verified by PCR analysis. Mice were housed in 
pathogen-free conditions under diurnal lighting alternated with a dark phase between 18.00 
– 6.00, allowed daily food “Zuchthaltungsfutter Maus-Ratte 10 H 10” (Eggersmann) and 
water ad libitum. All mice were repeatedly tested for the presence of pathogens and were 
free of any pathogens according to the criteria of the Federation of Laboratory Animal 
Science Associations. 
 
 Radioactive substances 
[32P] gamma-ATP Hartmann Analytic, Braunschweig 
 
[14C] Sphingomyelin Perkin Elmer, Boston, MA, USA 
 
 
 Other materials 
ADEFO X-Ray Developer 
Concentrate 
Adefo Chemie GmbH, Dietzenbach 
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ADEFO X-Ray Fixer Concentrate Adefo Chemie GmbH, Dietzenbach 
 
CDP-Star Chemiluminescence 
Reagent 
PerkinElmer, Waltham, MA, USA 
Coverslips 12 mm diameter Carl-Roth GmbH & Co, Karlsruhe 
Cuvettes 10 x 4 x 45 mm Sarstedt, Numbrecht 
 
FACS Polystyrene Round-Bottom 
Tubes 
Beckton Dickinson Labware, Le Point de Claix, 
France 
 
LeicaConfocal software (Leica) 
 
Leica Microsystems, Germany 
 
Microscopy glass slides 76 x 26 mm Engelbrecht, Edermunde 
 
Minisart syringe filters 
 
Vivascience AG, Hannover 
Parafilm Peckiney, Chicago, IL, USA 
 
Steritop Vacuum-driven disposable 
top filters 
Millipore, Billerica, MA, USA 
 
 
tryptic soy agar plates 
 
BD Biosciences, Heidelberg, Germany 
 
Whatman filter paper Whatman, Maidstone, UK 
 
X-Ray films Amersham Biosciences, Buckinghamshire, UK 
 
 
 Special laboratory equipment 
Portable Datalogging 
Spectrophotometer 
Bachofer, Reutlingen, Germany 
 
 
fluorescence-activated cell sorter FACScalibur, BD Biosciences, San Jose, CA, 
USA 
 
Fluorescence Microplate Reader BMG Labtech, Offenburg, Germany  
 
Leica TCS SP confocal microscope 
equipped with a 100× oil objective 
Leica Microsystems, Wetzlar, Germany 
 
 
Sonorex bath sonicator 
 
Bandelin electronic, Berlin, Germany 
TriCarb Liquid scintillation 
Analyzer 
 
Perkin Elmer, USA 
 
Tropix system 
 
Bedford, MA 
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 Buffer and Solutions 
Anesthesia cocktail 10% Ketamin 2ml 
2% Xylazin 0.5ml 
dH2O 10ml 
ASM lysis buffer 0.2% Trition X-100 
50 mM sodium acetate pH 5.0 
 
DAG-assay Buffered Saline Solution 135 mM NaCl 
1.5 mM CaCl2 
0.5 mM MgCl2 
5.6 mM Glucose
 
10 mM Hepes pH 7.2 
 
DAG-assay detergent solution 7.5% N-octylglucopyranoside
 
5 mM cardiolipin
 
1 mM DETAPAC 
 
DAG-kinase diluents 1 mM DETAPAC (pH 6.6) 
0.01 M imidazole/HCl 
 
DAG-kinase reaction buffer 100 mM imidazole/HCl pH 6.6 
100 mM NaCl 
25 mM MgCl2 
2 mM EDTA
 
2.8 mM DTT 
5 uM ATP
 
10 uCi [32P] gamma-ATP 
 
HEPES buffer 132 mM NaCl 
20 mM Hepes pH 7.4 
5 mM KCl
 
1 mM CaCl2 
0.7 mM MgCl2 
0.8 mM MgSO4 
 
Lysosomal calibration buffer 120 mM KCl 
20 mM NaCl 
1 mM CaCl2 
1 mM MgCl2 
10 mM HEPES 
adjusted the pH to either 4.5, 5.0, 5.5, 6.0, or 
6.5, respectively 
Mowiol 6 g Glycerol 
2.4 g Mowiol 
6 ml H2O 
12 ml 0.2 M Tris pH 8.5 
0.1% DABCO 
 
PA medium 
 
500 ml RPMI-1640 
1 mM Hepes pH 7.4 
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PFA 2%  
 
2.5 ml PFA stock solution 
7.5 ml PBS 
 
PFA stock solution 8g PFA 
100 ml PBS 
 
Phosphate Buffered Saline (PBS) 137 mM NaCl 
2.7 mM KCl
 
7 mM CaCl2 
0.8 mM MgSO4 
1.4 mM KH2PO4 
6.5 mM Na2HPO4 
 
SDS-sample buffer 62.5 mM Tris pH 6.8,  
10% glycerol,  
2% SDS,  
0.04% bromphenol blue 
5% β-mercaptoethanol 
 
10 x TBE 890 mM Tris Base 
890 mM Boric Acid 
20 mM EDTA 
 
Tissue Lysis Buffer (TLB) 
 
10% 10 x PCR buffer 
0.5 mM MgCl2 
0.045% Tween-20 
0.045% NP-40 
300 µg/ml Proteinase K 
 
10 x Tris-buffered Saline-
supplemented with 0.1% Tween-20 
(TBS-T) 
200 mM Tris pH 7.4 
1500 mM NaCl 
1% Tween-20 
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3. METHODS 
 Isolation of alveolar macrophages from mice  
Lung macrophages were freshly isolated by bronchoalveolar lavage (BAL) from 6-8 week 
old mice. To this end, the mice were anesthetized with i.p. injection of 250 µL anesthesia 
cocktail and then the trachea was opened and cannulated with a polyethylene tube. Then, 
the lung was lavaged with a total of 15 ml ice-cold PBS (see Materials) in 20 aliquots (0.75 
ml/aliquot). Approximately 0.5 to 1×106 cells per mouse were consistently obtained. Cells 
were pelleted by centrifugation at 300×g for 15 min, resuspended, and cultured for 1h in 
PA medium (see Materials) in 24-well plates at a density of 105 cells per well. Because 
alveolar macrophages are extremely adhesive cells, after other blood cells were washed off, 
we were left with a pure cell culture in which more than 99% of cells were macrophages, 
as confirmed by flow cytometry after staining with FITC-coupled anti-CD11b antibodies. 
 Infection experiments  
The laboratory strains of P. aeruginosa ATCC 27853 were plated overnight on tryptic soy 
agar plates at 37°C, resuspended in 20 mL tryptic soy broth (TSB) at an optical density of 
0.25 at 550 nm, and incubated at 37°C for 1 h with shaking at 120 rpm. Bacteria were 
harvested in the early logarithmic growth phase and washed twice in PA medium. 
Macrophages were infected with P. aeruginosa at a multiplicity of infection (MOI) of 100 
or 1 (1 macrophage was infected with 100 or 1 bacteria). For P. aeruginosa ATCC 27853 
infection, synchronous infection conditions and an enhanced bacterium-host cell 
interaction were achieved by a 2-min centrifugation (300×g) of the bacteria onto the cells. 
The end of the centrifugation step was defined as the starting point of all infections. For P. 
aeruginosa PAO1 infection, bacteria were cultured and harvested similar to strain ATCC 
27853, but were added without centrifugation. Bacterial CFUs were counted by serial 
dilution and plating on TSB agar plates.  
 Acid sphingomyelinase activity assay 
Activity of the acid sphingomyelinase was measured by the consumption of radioactive 
[14C]-sphingomyelin to ceramide and [14C]-phosphorycholine. To this end, 105 cells in a 
12-well plate were infected, washed and lysed in 200 µl ice-cold ASM lysis buffer (see 
Materials) with a cocktail of protease and phosphatase inhibitors (see Materials). The cells 
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were removed from the plate, transferred into eppendorf tubes and immediately sonicated 
three times (3×10 s). The substrate ([14C]-sphingomyelin) was dried prior to use and 
resuspended in ASM lysis buffer followed by 10 min bath sonication to promote the 
formation of micelles. The lysates were incubated with 0.02 µCi [14C]-sphingomyelin for 
30 min at 37 °C. The reaction was stopped by addition of 1 ml of CHCl3:CH3OH (v/v). 
Phases were separated by 5 min centrifugation at 14,000 rpm and an aliquot of aqueous 
phase was applied for liquid scintillation counting. Hydrolysis of [14C]-sphingomyelin by 
sphingomyelinase results in release of [14C]-choline chloride into the aqueous phase, 
whereas ceramide and unreacted [14C]-sphingomyelin remain in the organic phase. 
Therefore, the release of [14C]-choline chloride (pmol/105 cells/h) serves to determine the 
activity of the acid sphingomyelinase.  
 Ceramide measurement by DAG kinase assay  
Cellular ceramide was measured by DAG kinase assay, in which ceramide is converted to 
a quantifiable product (ceramide-1-phosphate) by transfer of [32P]-phosphate to [32P]-
gamma ATP to ceramide. To this purpose, cells were infected as above, extracted in 
CHCl3:CH3OH:1 N HCl (100:100:1, v/v/v). The resulting biphasic mixture is composed of 
a lower liquid-containing organic phase, and an upper aqueous phase. The upper phase and 
any resulting precipitate at the interface were removed and the lipids in the lower organic 
phase were collected, dried by evaporation of the chloroform in a SpeedVac. The dried 
lipids were subjected to alkaline hydrolysis of diacylglycerol in 0.1 N methanolic KOH at 
37 °C for 60 min. Samples were re-extracted, the lower phase dried, and 20 µl of a 
detergent solution consisting of DAG-assay detergent solution (see Materials) were added 
to the samples. Samples were sonicated for 10 min in a bath sonicator, and 50 µl of DAG-
kinase reaction buffer (see Materials), and 10 µl of DAG kinase diluted with DAG-kinase 
diluents (see Materials) were added. The kinase reaction was performed for 30 min at room 
temperature, and the samples were extracted in 1 ml of CHCl3:CH3OH:1 N HCl (100:100:1, 
v/v/v), 170 µl of DAG-assay buffered saline solution (see Materials) and 30 µl of a 100 
mM EDTA solution. Samples were vortexed and centrifuged, the lower phase was 
collected, dried, and dissolved in 20 µl of CHCl3:CH3OH (1:1, v/v). Lipids were separated 
on a Silica G-60 TLC plate. A solvent system of CHCl3:CH3COCH3:CH3OH:CH3COOH: 
H2O (10:4:3:2:1, v/v/v), was added to the TLC chamber, and was allowed to saturate the 
atmosphere for 1 h by using a sheet of Whatman filter paper. The silica plates were loaded 
with the solubilized lipids, placed into the TLC chamber and the solvent front was allowed 
to migrate to the top of the plate. The plate was then removed, air dried and exposed to X-
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ray films for 24 hrs. Ceramide spots were identified by comigration with a C16-ceramide 
standard, removed from the plate, and incorporation of 32P into ceramide was quantified by 
liquid scintillation counting. Comparison with a standard curve using C16-ceramide 
permitted the determination of ceramide amounts. 
 Flow cytometry analysis of surface ceramide 
Fluorescence Activated Cell Sorting (FACS) allows the analysis and sorting of cell 
populations based on their morphology and fluorescence after staining with different 
fluorochrome-conjugated antibodies. To detect surface ceramide in the plasma membrane, 
cells were left uninfected or infected with P. aeruginosa and fixed in 2% PFA for 10 min. 
The cells were incubated in PBS/5% fetal calf serum (FCS) for 30 min at room 
temperature to block unspecific binding sites and stained with a ceramide antibody (1:200 
dilution) for 1 hour. Cells were then washed in PBS containing 1% FCS and stained for 45 
min with Cy3-goat anti-mouse IgM. After a final PBS wash, cells were resuspended in 300 
µL FACS buffer, transferred into FACS polystyrene tubes and analyzed on a fluorescence-
activated cell sorter (see material).  
 Determination of ROS burst 
ROS production can be determined by using a ROS probe, H2DCFDA (see materials), 
which is only fluorescent when it is oxidized by ROS. To measure ROS burst, cells were 
cultured in 96-well plates (105cells/well) and incubated with 10 µM H2DCFDA for 30 min 
at 37oC. Cells were infected with P. aeruginosa for 30 min and the fluorescence was 
determined by fluorescence micro-plate reader at excitation/emission: 485/520 nm. 
Relative fluorescence unit (RFU) over time (∆RFU/min) was used to represent total ROS 
release. 
 Flow cytometry analysis of intracellular ROS accumulation 
To determine intracellular ROS production, cells were loaded with 10 µM cell membrane 
permeable H2DCFDA for 30 min at 37 oC. After incubation, cells were extensively washed 
with PBS to remove extracellular H2DCFDA and further incubated at 37 oC for 10 min to 
allow cleavage of H2DCFDA to cell membrane impermeable H2DCF by intracellular 
esterase. After infection, the cell fluorescence was determined by flow cytometry analysis.   
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 Fluorescence microscopy 
Cells were left uninfected or infected with P. aerugionsa as above and fixed in 2% 
PFA/PBS for 10 min. For intracellular staining, cells were permeablized with 0.1% Triton 
X-100/PBS for 15 min at room temperature. Cells were washed again with PBS and 
incubated for 30 min in PBS supplemented with 5% FCS to block nonspecific binding sites. 
Cells were washed and incubated for 45 min with either anti-ceramide IgM (see Materials) 
and anti-gp91phox IgG, or a anti-phospho-c-Jun IgG. Cells were then washed in PBS with 
0.05% Tween-20 and incubated for an additional 45 min with FITC-labeled goat anti-
mouse IgG, Cy3-anti-rabbit IgG or Cy5-anti-mouse IgM F(ab’)2 fragments antibodies. 
After a final PBS wash, cells were mounted on glass coverslips with moviol. Control 
experiments were performed with irrelevant mouse or rabbit antibodies and secondary 
antibodies. Control antibodies did not significantly bind to the cells. Cells were examined 
on a Leica TCS SP confocal microscope equipped with a 100× oil objective and images 
were analyzed using LeicaConfocal software (Leica).  
 Immunoblot analyses 
Cells were infected and lysed in SDS-sample buffer (see material), boiled, and sonicated 
(3×10 s) on ice to break chromosomal DNA and decrease sample viscosity. Then proteins 
were separated by 10% SDS–PAGE and transferred to nitrocellulose membranes. The blots 
were blocked in 4% BSA in TBS-T and incubated overnight at 4 oC with anti-phospho-
JNK (1:1000 dilution in 4% BSA) or anti-JNK1 (1:1000 dilution) antibodies. Blots were 
labeled with alkaline phosphatase-coupled secondary antibodies (see material) and 
developed using the Tropix system. 
 Analysis of lysosomal pH   
To observe lysosomal alkalinization, we incubated lung macrophages in PBS buffer with 
or without 100 nM bafilomycin, an H+-ATPase pump inhibitor (see material), for 30 min. 
The cells were then loaded with LysoSensor Green DND-189 (1 µM) in PBS buffer for 15 
min at 37oC. Cells were washed twice with PBS and immediately visualized with a Leica 
SP2 confocal microscope. We measured the relative mean fluorescence intensity of at least 
200 cells per sample. To obtain a pH standard curve, we loaded cells with LysoSensor 
Green DND-189 for 15 min at 37oC; the lysosomal pH was equalized by incubating cells 
for 15 min at 37°C either in PBS containing the ionophore nigericin (10 µM) or in a 
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lysosomal calibration buffer (see material). We observed no differences in fluorescence 
between the cells incubated in PBS and those incubated in the HEPES buffers.  
 
To determine whether LysoSensor Green DND-189 and TMR-dextran (10 kDa) target the 
same vesicle population, we incubated lung macrophages with TMR-dextran of various 
concentrations (1 mg/mL, 200 µg/mL, 50 µg/mL, 20 µg/mL and 10 µg/mL) in PA medium 
for 1 h at 37oC and then washed them with PBS. Cells were reincubated in fresh medium at 
37oC for 1 h to allow TMR-dextran to accumulate in lysosomes. The cells were then 
loaded with LysoSensor Green DND-189 for 15 min at 37oC, washed twice, and analyzed 
as described above. When indicated, cells were stained with LysoSensor Green DND-153 
(1 µM) according to a protocol similar to that used for LysoSensor Green DND-189. For 
flow cytometry, the macrophages were labeled as above, carefully removed from the 
culture plates, and immediately analyzed with a fluorescence-activated cell sorter.  
 
 Bactericidal capability assay 
To determine bactericidal capability, we cultured macrophages in 96-well plates (105 cells 
per well) and infected them with P. aeruginosa strain ATCC 27853 or PAO1 opsonized in 
5% mouse serum (MOI, 1). Phagocytosis of ATCC 27853 was synchronized by 
centrifugation at 300×g for 5 min, and macrophages were infected for 20 min at 37oC. 
Infection with PAO1 bacteria was performed without centrifugation. Macrophages were 
then gently washed three times with sterile PBS for removal of extracellular or attached 
bacteria. Macrophages were further infected for 0 or 60 min at 37oC in the absence or 
presence of the NADPH oxidase inhibitor apocynin (100 µM). After infection, 
macrophages were incubated with 20 µL saponin (5 mg/mL) for 5 min for release of 
intracellular bacteria. Then 100 µL tryptose phosphate broth and 15 µL MTT in PBS (5 
mg/mL) were added to each well, and the cells were incubated at 37oC for 4 h. Reactions 
were stopped by adding 100 µL isopropanol with 0.04 M HCl, and absorbance (A570nm) 
was measured at 570 nm with a microplate reader (see material). To obtain the A570nm-CFU 
relationship, we incubated 104 to 105 P. aeruginosa ATCC 27853 or PAO1 bacteria with 
100 µL tryptose phosphate broth and 20 µL MTT in PBS (5 mg/mL) without macrophages 
for 4 h (see Figure 3.1 below).  
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Figure 3.1 Representative standard curve for A570nm-CFU relationship. 
 
 Cytokine release 
Macrophages were cultured in 24-well plates (5×105 cells per well in 1 mL PA medium) 
and infected with the P. aeruginosa strains ATCC 27853 or PAO1 (MOI 100) for 2 h. 
Then the total mixture was transferred to an eppendorf tube and KC and MIP-2 levels in 
the supernatants were determined by ELISA according to the manufacturer’s instructions.  
 DNA techniques 
 DNA isolation from mouse tails 
For genotyping of Asm-deficient mice, app. 1-2 mm of mouse tail was cut and placed into 
80 µl Tissue Lysis Buffer (TLB). The samples were incubated at 560C overnight and the 
volumes were raised to 800 ul with autoclaved ddH2O.  
 
 Polymerase Chain Reaction (PCR) for acid sphingomyelinase or Cftr 
For the identification of acid sphingomyelinase wild-type, acid sphingomyelinase 
heterozygotes or Asm-deficient mice by PCR, 1 µL of overnight tail digest was added to 
1.2 µL 10 x PCR Buffer, 2.5 mM MgCl2, 1 µL dNTP mix 5 units/mL Taq Polymerase and 
0.1 µL each of primers ASM-PA1-2, ASM-PA2-2 and ASM-PS-2 in 0.2 ml PCR tubes. 
The temperature of the lid of the PCR machine was raised to 104oC and the temperature of 
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the PCR block was raised to 96oC for 17 min, after which the following cycle was carried 
out 35 times: 
Denaturation: 95oC for 1 min 
Annealing: 58oC for 1 min 
Elongation: 72oC for 1 min 45 sec 
After the last cycle, the PCR block remained at 72oC for 5 min, after which the samples 
were placed at 4oC.  
 
For the identification of wild-type, Cftr heterozygotes or Cftrtm1Unc-Tg(FABPCFTR) 
(abbreviated CftrKO) by PCR, 2.5 µL of overnight tail digest was added to 16.25 µL dH2O, 
2.5 µL 10 x PCR Buffer, 0.5 µL dNTP, 0.25 µL Taq Polymerase, 0.5 µL dNTP mix and 1 
µL each of primers IMR1125, IMR1126 and IMR1127 in 0.2 ml PCR tubes. The 
temperature of the lid of the PCR machine was raised to 104oC and the temperature of the 
PCR block was raised to 96oC for 17 min, after which the following cycle was carried out 
35 times: 
Denaturation: 95oC for 1 min 
Annealing: 58oC for 1 min 
Elongation: 72oC for 1 min 45 sec 
After the last cycle, the PCR block remained at 72oC for 5 min, after which the samples 
were placed at 4oC.  
 
For the identification of wild-type, Cftr heterozygotes or B6.129P2(CF/3)-CftrTgH(neoim)Hgu 
(abbreviated CftrMHH), two PCR reactions are performed. First PCR is designed to detect 
3473 fragment (mutant fragment) which includes 2.5 µL of overnight tail digest was added 
to 18.25 µL dH2O, 2.5 µL 10 x PCR Buffer, 0.5 µL dNTP, 0.25 µL Taq Polymerase, 0.5 
µL dNTP mix and 0.5 µL each of primers 3473f and 3473r in 0.2 ml PCR tubes. The 
second PCR is designed to detect 5012 fragment (wild-type fragment) which includes 2.4 
µL of overnight tail digest was added to 2.9 µL dH2O, 6 µL 2 x PCR Buffer mix D, 0.3 µL 
Taq Polymerase, 0.25 µL dNTP mix and 0.5 µL each of primers 5012f and 5012r in 0.2 ml 
PCR tubes. The temperature of the lid of the PCR machine was raised to 104oC and the 
temperature of the PCR block was raised to 96oC for 17 min, after which the following 
cycle was carried out 35 times: 
Denaturation: 95oC for 1 min 
Annealing: 58oC for 1 min 
Elongation: 72oC for 1 min 45 sec 
Methods 
 
32 
After the last cycle, the PCR block remained at 72oC for 5 min, after which the samples 
were placed at 4oC.  
 
For the identification of mycoplasma by PCR, 1 ul of cell digest (see 3.7.1.2) was added to 
2.5 ul 10 x PCR Buffer, 4.1 mM MgCl2, 0.5 ul dNTP mix 1.25 units/ml Taq Polymerase 
and 0.25 each of primers P1 and P4 in 0.2 ml PCR tubes. The temperature of the lid of the 
PCR machine was raised to 1040C and the temperature of the PCR block was raised to 
960C for 17 min, after which the following cycle was carried out 25 times: 
Denaturation: 950C for 1 min 
Annealing: 600C for 1 min 
Elongation: 720C for 1 min 30 sec 
After the last cycle, the PCR block remained at 720C for 7 min, after which the samples 
were placed at 40C.  
 
 Agrose gel electrophoresis 
To analyse the products of the PCR, a 1% agarose gel was poured in TBE buffer (see 
Materials) that contained 0.01 µg/ml ethidium bromide. The samples (15 µl) were loaded 
on the gel along with 0.1 µg/µl of a 100-bp-standard. The gel was run under 5 V/cm 
current. Visualization of the DNA fragments was performed under UV-light.  
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4. RESULTS 
4.1 Role of acid sphingomyelinase in mediating ROS production during 
pulmonary P. aeruginosa infections of alveolar macrophages 
4.1.1 P. aeruginosa infections activate acid sphingomyelinase and release ceramide 
in lung alveolar macrophages 
Acid sphingomyelinase has been recently shown to play a critical role in host-pathogen 
interactions (Grassmé et al., 2003; McCollister et al., 2007). To investigate whether acid 
sphingomyelinase is involved in regulating ceramide production in macrophages upon P. 
aeruginosa infection, we infected alveolar macrophages with P. aeruginosa and 
determined the enzymatic activity of the acid sphingomyelinase and the formation of 
ceramide. The results reveal a very rapid activation of the acid sphingomyelinase upon P. 
aeruginosa infection peaking at approximately 15 min after infection (Figure 4.1A). 
Enhanced activity of the acid sphingomyelinase correlated with increased ceramide 
concentrations in wild type macrophages after P. aeruginosa infection (Figure 4.1B). This 
decrease might be mediated by consumption of ceramide by host cell enzymes, but also by 
the ceramidase activity from P. aeruginosa (Okino and Ito. 2007). Further, surface 
ceramide release was detected in wild type macrophages as determined by flow cytometry 
using monoclonal anti-ceramide antibodies. Deficiency of the acid sphingomyelinase in 
macrophages isolated from Smpd1–/– mice abrogated both, the surface release of ceramide 
(Figure 4.1C) indicating the importance of the acid sphingomyelinase for the induction of 
macrophage death by P. aeruginosa.  
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Figure 4.1 P. aeruginosa infections induce acid sphingomyelinase activation and ceramide 
generation. 
(A) P.aeruginosa activates acid sphingomyelinase in macrophages. Freshly isolated mouse alveolar 
were infected (MOI = 100, 0-60 min), lysed and assayed for acid sphingomyelinase activity.  
(B) DAG kinase assay for ceramide content in macrophages upon P. aeruginosa infections (MOI = 
100, 0-60 min). 
(C) Lung alveolar macrophages isolated from C57BL/6 wild type (WT) or Smpd1-/- (KO) mice 
lacking acid sphingomyelinase activity were left uninfected (thin line) or infected (bold line) with P. 
aeruginosa for 15 minutes. Surface ceramide release was determined by flow cytometry using Cy3-
labeled anti-ceramide antibodies. A representative of three experiments is shown. Significant 
differences between infected and non-infected controls were determined by t-test and are indicated 
by asterisk, respectively (* P<0.05, t-test).  
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4.1.2 Acid sphingomyelinase is necessary for P. aeruginosa-induced ROS production 
Previous studies showed a critical role of the acid sphingomyelinase in ROS production in 
macrophages, hepatocytes and endothelial cells (Zhang et.al, 2007; Hatanaka et.al, 1998; 
Reinehr et.al, 2005). Since ROS are critical factors for host-pathogen interactions, we 
tested whether acid sphingomyelinase mediates P. aeruginosa-triggered ROS production.  
  
To determine the ROS burst in macrophages, cells were pre-incubated with H2DCF-DA, a 
ROS probe, and then infected with P. aeruginosa ATCC 27853 for 30 min. As shown in 
Figure 4.2A, P. aeruginosa induced ROS burst in wild type cells, while no ROS-release 
was observed in Smpd1-/- cells after 30 min infection.  
 
To determine intracellular ROS accumulation in macrophages, cells were loaded with the 
cell membrane permeable ROS probe, H2DCF-DA. Extracellular H2DCF-DA was washed 
off by PBS after the loading period. Cells were further incubated for 10 min at 37oC to 
allow cleavage of H2DCF-DA to cell membrane impermeable H2DCF by intracellular 
esterase. Then cells were infected and DCF fluorescence was determined by flow 
cytometry. As shown in Figure 4.2B, P. aeruginosa time-dependently increased 
intracellular ROS in wild type (WT) macrophages, whereas no increase was observed in 
Smpd1-/- (KO) cells. It has been well documented that NADPH oxidase–derived 
superoxide production is a primary source of ROS generation in macrophages and 
neutrophils upon bacterial infection (Djaldetti et al, 2002; Karupiah et al, 2000). Consistently, 
DPI (50 µM, Sigma), a NADPH oxidase inhibitor, significantly attenuated P. aeruginosa–
induced ROS production (Figure 4.2B). Taken together, these studies demonstrate that 
acid sphingomyelinase mediates P. aeruginosa–induced ROS production via activation of 
NADPH oxidase. 
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Figure 4.2 P. aeruginosa infections induce NADPH oxidase-derived ROS generation. 
 (A) To determine ROS burst, wild type (WT) or Smpd1-/- (KO) macrophages were incubated with 
a fluorescence probe, H2DCFDA. Cells were infected for 30 min and fluorescence was determined 
by a fluorescence micro-plate reader. Relative fluorescence unit (RFU) over time (∆RFU/min) was 
used to represent ROS release.  
(B) Intracellular ROS accumulation is dependent on acid sphingomyelinase and NADPH oxidase 
activity. Wild type or Smpd1-/- macrophages were loaded with H2DCFDA, in the absence or 
presence of DPI (50 µM), a NADPH oxidase inhibitor. Cells were infected for the indicated time 
and analyzed by FACS. Relative ROS levels were used to indicate intracellular ROS accumulation. 
Data are mean ± SD of four independent experiments. 
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4.1.3 Acid sphingomyelinase mediates P. aeruginosa-induced formation of 
ceramide-enriched membrane platforms 
Activation of acid sphingomyelinase correlated with a release of ceramide in lung 
macrophages upon P. aeruginosa infection, which may induce formation of ceramide-
enriched membrane platforms. NADPH oxidase consists of two membrane-bound subunits, 
gp91phox and p22phox, which form a flavocytochrome b558 complex, and cytosolic subunits 
p47phox, p40phox, p67phox and the small GTPase Rac, which translocate to the membrane to 
assemble the active complex following cell activation (Vilhardt et al., 2004). Thus, the 
ceramide-enriched membrane platforms may serve for aggregating subunits of NADPH 
oxidase and activation of this enzyme complex.  
 
This led us to examine whether acid sphingomyelinase is required for P. aeruginosa-
induced formation of ceramide-enriched membrane platforms. Confocal fluorescence 
microscopy studies reveal that P. aeruginosa infection (MOI = 100, 15 min) induced 
formation of ceramide-enriched platforms in wild type cells (Figure 4.3A). Ceramide-
enriched platforms were observed as early as 1 min after infection peaking at about 5 min 
(ceramide clustering in around 80% of all cells). In marked contrast, ceramide-enriched 
membrane platforms were absent in acid sphingomyelinase-deficient cells after infection 
(Figure 4.3A). Quantitative analysis of cells positive for ceramide-enriched membrane 
platforms demonstrates that acid sphingomyelinase is essential for P. aeruginosa-induced 
formation of ceramide-enriched membrane platforms (Figure 4.3B). 
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Figure 4.3 P. aeruginosa infections induce formation of ceramide-enriched membrane 
platforms. 
 (A) P. aeruginosa ATCC 27853 (PA) infection results in rapid clustering of ceramide in the 
membrane to form ceramide-enriched platforms. Macrophages were infected, fixed and stained 
with Cy3-labeled anti-ceramide. Representative confocal fluorescence microscopy images of WT 
or acid sphingomyelinase-deficient Smpd1-/- (KO) cells either uninfected (No infection) or infected 
for 15 minutes (PA 15 min) are shown.  
(B) The quantitative analysis of the data from four independent experiments, which each included 
analysis of 200 cells/time point, shows the formation of ceramide-enriched membrane platforms in 
a large proportion of the cells. Displayed are the percentages of cells with a ceramide-enriched 
membrane platform at indicated time points. Ceramide-enriched membrane platforms were absent 
in Smpd1-/- cells.  
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4.1.4 P. aeruginosa-induced activation of NADPH oxidase via ceramide-
enriched membrane platforms 
To explore the mechanism how acid sphingomyelinase activation leads to NADPH 
oxidase-derived ROS production, we examined whether ceramide-enriched membrane 
platforms are involved in aggregation of gp91phox, a major membrane subunit of NADPH 
oxidase. Co-staining of ceramide and gp91phox demonstrates that gp91phox aggregates in and 
co-localizes with ceramide-enriched platforms (Figure 4.4), events that were absent in 
Smpd1-/- cells revealing a critical role of the acid sphingomyelinase for the formation of 
active NADPH-oxidase. These data indicate that, in P. aeruginosa–induced acid 
sphingomyelinase-mediated redox signaling, ceramide-enriched membrane platforms serve 
to aggregate NADPH oxidase leading to activation of this enzyme and subsequent ROS 
production.  
 
 
 
Figure 4.4 NADPH oxidase clusters in ceramide-enriched membrane platforms upon 
infection. 
Cells were infected with P. aeruginosa ATCC 27853 (PA) as in Figure 4.3 and confocal 
microscopy studies were performed using FITC-labeled anti-gp91phox (against a major membrane 
subunit of NADPH oxidase) and Cy3-labeled anti-ceramide antibodies in wild type cells. The 
images shown are representative of three independent experiments.  
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4.1.5 Redox regulation of acid sphingomyelinase activation and membrane platform 
formation  
The studies presented above indicate that acid sphingomyelinase controls ROS-generation 
upon P. aeruginosa infection. However, recent studies have suggested that acid 
sphingomyelinase is also subject to redox regulation (Zhang et.al, 2007; Dumitru and 
Gulbins, 2006; Qiu et.al, 2003; Scheel-Toellner et.al, 2004). Therefore, we first examined 
whether there is also a feedback regulation of ROS on acid sphingomyelinase activation 
upon P. aeruginosa-infection. As shown in Figure 4.5A, we detected that P. aeruginosa-
induced acid sphingomyelinase activation was inhibited in the cells by treatment either 
with the NADPH oxidase inhibitor DPI (50 µM), or the H2O2 degrading enzyme catalase 
(10 unit/ml). Vice versa, acid sphingomyelinase activity was increased by H2O2 (1 mM). 
Thus, these data suggest that acid sphingomyelinase-mediated generation of ROS amplifies 
P. aeruginosa-induced acid sphingomyelinase activation in a positive feedback manner.   
 
Next, we determined whether ROS has a similar feedback effect on acid 
sphingomyelinase-mediated formation of ceramide-enriched membrane platforms. P. 
aeruginosa-induced membrane platform formation was diminished by DPI or catalase, 
while H2O2 dramatically increased ceramide-enriched platform formation in wild type, but 
not in Smpd1-/- cells, suggesting that acid sphingomyelinase is essential for ROS-induced 
formation of membrane platforms (Figure 4.5B). 
 
These data raise the question whether P. aeruginosa activate acid sphingomyelinase first, 
which then triggers ROS that maintain the activity of the acid sphingomyelinase high or 
vice versa. DPI or catalase reduced, but not completely blocked P. aeruginosa-induced 
acid sphingomyelinase activation after 15 min infection (Figure 4.5A, DPI vs. DPI+PA 
and Catalase vs. Catalase+PA), whereas early release of ROS was completely prevented in 
Smpd1-/- cells Figure 4.2A). These data indicate that an initial ROS-independent activation 
of the acid sphingomyelinase results in generation of ceramide-enriched membrane 
platforms that serve to release ROS upon infection. ROS keep the activity of the acid 
sphingomyelinase high leading to enhanced formation of ceramide-enriched membrane 
platforms and further ROS-release in a positive feed-forward loop.    
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Figure 4.5 Redox regulation of acid sphingomyelinase (Asm) activation and ceramide-
enriched membrane platform formation. 
Macrophages were left untreated or treated with a NADPH oxidase inhibitor, DPI (50 µM) or a 
H2O2 degrading enzyme, catalase (10 unit/ml) for 30 min. Cells were infected with P. aeruginosa 
ATCC 27853 (PA) for 15 min and applied for acid sphingomyelinase activity assay or confocal 
microscopy. In parallel, effects of H2O2 (1 mM for 5 and 15 min) on acid sphingomyelinase 
activity and ceramide-enriched membrane platform formation were examined. (A) Acid 
sphingomyelinase activation upon infection was blocked by NADPH oxidase inhibition 
(DPI+PA) or ROS scavenging (catalase+PA), while enhanced oxidative stress by H2O2 increased 
acid sphingomyelinase activity. (B) Formation of ceramide-enriched membrane platforms was 
prevented by DPI and catalase. Further, acid sphingomyelinase activity is required for oxidative 
stress-induced formation of ceramide-enriched membrane platform since H2O2-induced ceramide 
clustering was observed in wild type, but not Smpd1-/- cells. Data for panels A and B are mean ± 
SD of three independent experiments. Significant differences between infected or H2O2 treated cells 
and non-infected controls were determined by t-test and are indicated by asterisk. Significant 
differences between infected cells treated with DPI or catalase and left untreated were determined 
by t-test and indicated by delta (P<0.05). 
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4.1.6 P. aeruginosa-induced activation of JNK is acid sphingomyelinase- and ROS-
dependent 
Ceramide and ROS have been reported to activate JNK (Verheij et al., 1996; Haimovitz-
Friedman et al., 1997; Basu et al., 1998; Shen et al., 2004). Therefore, we examined 
whether acid sphingomyelinase-mediated redox signaling is involved in P. aeruginosa-
induced JNK activation. Alveolar macrophages were infected and lysed in 1x SDS sample 
buffer. JNK activation upon P. aeruginosa infection was detected in wild type cells as 
early as 5 min after infection, with maximum levels reached approximately 30 min after 
initiation of the infection (Figure 4.6A), while genetic deficiency of the acid 
sphingomyelinase prevented JNK activation by P. aeruginosa infection. Likewise, wild 
type cells treated with the NADPH oxidase inhibitor DPI (Figure 4.6A) failed to activate 
JNK after P. aeruginosa infection. Further, P. aeruginosa infection induced 
phosphorylation and nuclear translocation of c-Jun in wild type cells, which was also 
inhibited by DPI (Figure 4.6B).  
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Figure 4.6 Role of acid sphingomyelinase-mediated ROS in P. aeruginosa-induced JNK 
activation. 
(A) JNK activation requires acid sphingomyelinase and NADPH oxidase activation. Alveolar 
macrophages isolated from wild type or Smpd1-/- mice were infected with P. aeruginosa for 
indicated times and JNK activation was evaluated by Western blot analysis of phosphorylated 
isoforms p46 JNK1 (46 kDa, lower band) and p54 JNK2 (54 kDa, upper band). JNK activation was 
also evaluated in wild type cells pretreated with DPI (50 µM) for 30 minutes. JNK1 was probed as 
loading control. Density of the bands was scanned, quantified and relative phospho-JNK densities 
were normalized to the amount of JNK1. Summarized data for panels A are mean ± SD from each 
four independent experiments  
(B) c-Jun activation depends on NADPH oxidase activation. Wild type cells were treated with DPI 
(50 µM) for 30 minutes or left untreated, infected, permeabilized and stained with Cy3-labeled 
anti-phospho-c-Jun antibodies. c-Jun activation was evaluated by nuclear detection of 
phosphorylated c-Jun.  
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4.2 Role of Cftr in determine lysosomal pH in alveolar macrophages 
4.2.1 Cftr deficiency results in lysosomal alkanlization in lung alveolar macrophages  
To determine whether Cftr deficiency affects lysosomal pH, we stained freshly isolated 
alveolar macrophages with LysoSensor Green DND-189, which accumulates in acidic 
organelles and exhibits green fluorescence. The results demonstrated that Cftr-deficient 
macrophages obtained from CftrMHH mice exhibit much lower fluorescence intensity than 
do wild-type cells. This finding indicates that Cftr deficiency impairs the acidification of 
these vesicles (Figure 4.7A). Bafilomycin is known to specifically inhibit vacuolar type H+-
ATPase and, therefore, to elevate lysosomal pH (Banta et al, 1988). Pretreatment of cells 
with bafilomycin decreased LysoSensor fluorescence intensity in both wild-type and 
CftrMHH cells (Figure 4.7A). To obtain a standard curve for LysoSensor Green DND-189 
fluorescence, we permeabilized the cells with nigericin and incubated the cells that were 
previously stained with LysoSensor Green DND-189 in a calibration buffer with pH values 
ranging from 4.5 to 6.5. We found that the relative fluorescence of the LysoSensor Green 
DND-189 staining was linear over the investigated range of pH (Figure 4.7B). A linear, 
pH-dependent decrease of intracellular LysoSensor Green DND-189 fluorescence was 
observed in both wild-type and CftrMHH cells. FACS analysis confirmed that bafilomycin 
decreased LysoSensor Green DND-189 fluorescence in wild-type macrophages (Figure 
4.7C).  
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Figure 4.7 Cftr deficiency increases the pH of lysosomes 
(A) Wild-type (wt) or Cftr-deficient (CFMHH) macrophages were treated with bafilomycin (100 nM) 
for 30 min or left untreated. They were then stained with LysoSensor Green DND-189 and 
analyzed by fluorescence microscopy. Representative fluorescence images or the mean ± SD from 
four independent experiments are shown.  
(B) Macrophages were loaded with LysoSensor Green DND-189 and incubated with or without a 
calibration buffer adjusted to pH values ranging from 4.5 to 6.5. Relative LysoSensor Green DND-
189 fluorescence of samples with calibration buffer was calculated as the percentage of samples 
with a pH of 4.5. The results were repeated 3-times with similar results.  
(C) The panel displays a representative histogram produced by flow cytometric analysis of 
LysoSensor Green DND-189 fluorescence in wild-type macrophages with or without pretreatment 
with bafilomycin. The data are representative of those from three independent experiments.  
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4.2.2 Cftr regulates lysosomal pH of a sub-population of vesicles that stain 
differentially with LysoSensor Green DND-189 and TMR-dextran 
Next, we compared LysoSensor Green DND-189 staining of macrophages with TMR-
dextran labeling of wild-type and CftrMHH macrophages. Cells were incubated cells with 1 
mg/mL TMR-dextran and then stained with LysoSensor Green DND-189 (1 µM). The 
results show that LysoSensor Green DND-189 and TMR-dextran stain distinct vesicles 
(Figure 4.8A). Further, Cftr deficiency decreased LysosSensor DND-189 staining but had 
no effect on TMR-dextran staining (Figure 4.8A). The higher concentrations (1 mg/mL) of 
the weak base TMR-dextran very likely alkalinized the vesicles and thus prevented 
staining with LysoSensor Green DND-189, therefore, we also stained cells at lower 
concentrations of TMR-dextran (10, 20, 50, 200 µg/mL). As shown in Figure 4.8B, all 
vesicles that stained with TMR-dextran also stained with LysoSensor Green DND 189, but 
not all LysoSensor Green DN189-positive vesicles were also positive for TMR-dextran. 
Thus, these results indicate very clearly that Lysosensor Green DND-189 stains two 
populations of intracellular vesicles, one that is also stained by TMR-dextran and one that 
is not stained with TMR-dextran and probably consists of secretory lysosomes that are not 
stained with dyes that require internalization, such as TMR-dextran. Cftr deficiency 
substantially decreased the fluorescence intensity of LysoSensor Green DND-189 in these 
vesicles.  
 
 
 
 A 
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Figure 4.8 Lysosensor Green DND-189 targets a specific vesicle population that are not 
stained with TMR-dextran. 
(A) Wild-type (wt) or Cftr-deficient (CFMHH) macrophages were loaded with TMR-dextran (1 
mg/mL) and then stained with LysoSensor Green DND-189 and analyzed by fluorescence 
microscopy. Representative fluorescence images from four independent experiments are shown.  
(B) To determine which vesicles are stained with LysoSensor Green DND-189 and which with 
tetramethylrhodamine (TMR)-dextran, we loaded wild-type macrophages with lower concentration 
of concentrations of TMR-dextran and then stained them with LysoSensor Green DND-189. The 
results show that LysoSensor Green DND-189 also stains a vesicle population, which is not stained 
with TMR-dextran. Representative confocal fluorescence images from three independent 
experiments are shown. 
  
B 
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4.2.3 Cftr deficiency does not affect total uptake or retention of Lysosensor probes  
To exclude the possibility that Cftr-deficient cells have defects in the uptake or retention of 
LysoSensor probes, we stained 5×104 cells with LysoSensor Green DND-189, disrupted 
the cells in 200 µL pH calibration buffer (pH = 4 or 6.5) containing 1% Triton X-100, and 
then measured the total fluorescence intensity of the lysate with a fluorescence microplate 
reader (BMG Systems, Offenburg, Germany). No difference was found in the total 
fluorescence intensity of LysoSensor Green DND-189 between wild-type and Cftr-
deficient cells either at an acidic pH of 4 or at a higher pH of 6.5 (Figure 4.9A). 
We also stained the cells with LysoSensor Green DND-153, which exhibits bright 
fluorescence only at a neutral pH. The results demonstrated that at least some vesicles of 
Cftr-deficient macrophages exhibit a higher fluorescence intensity of LysoSensor Green 
DND-153 than do the vesicles of wild-type cells (Figure 4.9B). These data indicate that 
Cftr deficiency results in pH changes in some vesicles rather than in an alteration in the 
uptake or retention of LysoSensor probes. 
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Figure 4.9 Effect of Cftr deficiency on uptake and retention of LysoSensor probes and 
lysosome biogenesis. 
(A) Wild-type and Cftr-deficient (CftrMHH) macrophages were loaded with LysoSensor Green 
DND-189 and lysed in pH calibration buffer (pH = 4.0 or 6.5) containing 1% Triton X-100. Total 
LysoSensor Green DND-189 fluorescence was then determined with a fluorescence microplate 
reader. Results are shown as the mean ± SD of 4 independent experiments.  
(B) Macrophages were stained with TMR-dextran and LysoSensor Green DND-153, which is 
fluorescent at neutral pH. Representative confocal fluorescence images from three independent 
experiments are shown.  
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4.2.4 Cftr localizes within LAMP-1-positive vesicles  
To determine whether Cftr resides in lysosomal membranes, we double-stained cells for 
Cftr and lysosomal-associated membrane protein 1 (LAMP1). The results demonstrated 
that Cftr co-localizes with LAMP1 in some but not all vesicles of freshly isolated lung 
macrophages; this finding suggests that lysosomal membrane–associated Cftr directly 
contributes to the control of pH in lysosomes (Figure 4.10). No difference in LAMP1 
staining was found between wild-type and Cftr-deficient macrophages, a finding 
suggesting that lysosome biogenesis is not changed by Cftr deficiency (Figure 4.10). The 
fact that Cftr-deficient cells do not stain with the anti-Cftr antibodies indicates the 
specificity of the staining.  
 
 
 
Figure 4.10 Effect of Cftr deficiency on lysosome biogenesis. 
Macrophages were fixed, permeabilized, and stained with FITC-labeled anti-LAMP1, Cy3-labeled 
anti-Cftr, or both. Representative fluorescence images from three independent experiments are 
shown. 
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4.3 Role of Cftr in ceramide-mediated ROS production during 
pulmonary P. aeruginosa infections of alveolar macrophages 
4.3.1 Cftr deficiency results in ceramide accumulation in lung alveolar macrophages 
We have previously shown that Cftr-deficient epithelial cells accumulate ceramide 
(Teichgräber et al., 2008). We suggested that the impaired acidification of vesicles, cellular 
compartments, or both may cause an imbalance in the activities of acid sphingomyelinase 
and acid ceramidase, and that this imbalance may result in the accumulation of ceramide 
(Teichgräber et al., 2008). However, it is unknown whether ceramide also accumulates in 
Cftr-deficient macrophages. To confirm ceramide accumulation in Cftr-deficient 
macrophages, we performed DAG kinase assays that determine total cellular ceramide 
concentrations. We detected a substantial increase in ceramide concentrations in CftrMHH 
and CftrKO macrophages (Figure 4.11).  
 
 
Figure 4.11 Cftr deficiency results in ceramide accumulation. 
Diacylglycerol (DAG) kinase assays of total cellular ceramide contents demonstrate increased total 
levels of ceramide in Cftr-deficient (CFMHH and CFKO) macrophages compared to wild-type 
macrophages. Data are presented as the mean ± SD of results from 3 independent experiments. 
Significant differences of samples from Cftr-deficient compared to wild-type samples were 
determined by one-way ANOVA followed by a Bonferroni post-hoc t-test and are indicated by an 
asterisk (*) (P < 0.05).  
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4.3.2 Ceramide in wild-type and Cftr-deficient macrophages before and after 
infection with P. aeruginosa 
 
The ceramide levels in macrophages were also determined by con-focal fluorescence 
microscopy. Wild-type and Cftr-deficient alveolar macrophages obtained from CftrMHH 
mice were permeabilized and stained with anti-ceramide antibodies. We detected a marked 
accumulation of cellular ceramide in uninfected Cftr-deficient cells compared to wild-type 
cells (Figure 4.12). Infection with P. aeruginosa increased intracellular ceramide staining 
in wild-type cells but had only a minimal effect on ceramide concentrations in CftrMHH 
macrophages (Figure 4.12). Infection with P. aeruginosa increased intracellular ceramide 
staining in wild-type cells but had only a minimal effect on ceramide concentrations in 
CftrMHH macrophages (Figure 4.12). 
 
The data in Figure 4.2 have demonstrated that the activation of acid sphingomyelinase and 
the release of ceramide upon infection with P. aeruginosa trigger the release of ROS in 
macrophages. We therefore investigated whether P. aeruginosa infection induces co-
localization of ceramide with gp91phox, an important membrane-bound subunit of NADPH 
oxidase, in vesicles of wild-type cells, and whether Cftr is involved in the co-localization 
of gp91phox and ceramide. The results show that P. aeruginosa triggers co-localization of 
gp91phox and ceramide in wild-type macrophages. Some degree of co-localization of 
gp91phox and ceramide was observed in CftrMHH macrophages before infection with P. 
aeruginosa (Figure 4.12). However, infection failed to induce further co-localization of 
gp91phox and ceramide.  
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Figure 4.12 Cftr deficiency results in ceramide accumulation and co-localization with 
gp91phox. 
Macrophages were infected with P. aeruginosa strain ATCC 27853. For detection of intracellular 
ceramide and gp91phox, cells were washed, fixed, permeabilized, and stained with Cy3-labeled 
ceramide and FITC-labeled gp91phox antibodies. Shown are representative confocal fluorescence 
microscopic images of wild-type and Cftr-deficient (CftrMHH) cells that were either left uninfected 
or infected with P. aeruginosa (Pa; multiplicity of infection [MOI] = 100) for 15 min (n = 3). 
Representative fluorescence images from three independent experiments are shown. 
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4.3.3 Cftr deficiency impairs P. aeruginosa-induced clustering of gp91phox in 
ceramide-enriched membrane platforms 
Previous studies have shown that ceramide molecules form ceramide-enriched membrane 
platforms in the plasma membrane and that these ceramide molecules are crucially 
involved in signal transduction events that are controlled by ceramide (Grassmé et al., 
2001; Jin et al., 2008). To test whether P. aeruginosa infections trigger the formation of 
ceramide-enriched membrane domains in macrophages, we stained intact cells, i.e., cells 
that were not permeabilized, with anti-ceramide antibodies (Figure 4.13). The results show 
that P. aeruginosa induces massive clustering of ceramide in the plasma membrane of 
wild-type cells but that only very small ceramide-enriched membrane domains are 
observed in CftrMHH macrophages infected with P. aeruginosa (Figure 4.13). Co-staining 
with anti-gp91phox antibodies revealed that gp91phox is localized within ceramide-enriched 
membrane domains in wild-type macrophages (Figure 4.13). In contrast, no increase in the 
co-localization of gp91phox and ceramide was observed in CftrMHH macrophages upon 
infection with P. aeruginosa (please note that cells in Figure 4.13 are not permeabilized). 
However, Cftr deficiency alone resulted in some co-localization of ceramide and gp91phox 
in the plasma membrane already in uninfected cells. 
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Figure 4.13 Cftr deficiency impairs P. aeruginosa-induced clustering of gp91phox in 
ceramide-enriched membrane platforms. 
For detection of ceramide-enriched membrane platforms, macrophages were infected, fixed, and 
stained as in Figure 4.12 except that no permeabilization was performed since ceramide clusters 
would not be observed in permeabilized cells. Representative fluorescence images from three 
independent experiments are shown. 
 
Results 
 
56 
4.3.4 P. aeruginosa -induced ROS release is Cftr-dependent  
The impaired co-localization of gp91phox and ceramide in Cftr-deficient macrophages 
suggests that Cftr is also involved in the regulation of the release of ROS upon infection 
with P. aeruginosa. To examine ROS production by macrophages upon infection with P. 
aeruginosa, we loaded cells with H2DCF, an ROS probe and infected them with P. 
aeruginosa in the absence or presence of the ROS scavengers SOD and catalase. When the 
cells were not infected, there was no significant difference between wild-type and Cftr-
deficient cells in the increase of DCF fluorescence, although ROS production was slightly 
increased in CftrMHH cells. Infection with P. aeruginosa ATCC 27853 or PAO1 induced a 
substantial increase in DCF fluorescence in wild-type macrophages including ROS 
production but not in CftrMHH macrophages (Figure 4.14).  
 
 
Figure 4.14 Cftr deficiency impairs the production of reactive oxygen species by macrophages 
Macrophages were loaded with 2',7'-dichlorofluorescin (DCF), an ROS probe. The cells were then 
infected with P. aeruginosa ATCC 27853 or PAO1 strains (multiplicity of infection [MOI] = 100) 
for 1 h in the presence or absence of 100 U/ml superoxide dismutase (SOD, an ROS scavenger) and 
10 U/ml catalase. The change in DCF fluorescence was determined by using flow cytometry to 
measure the mean fluorescence intensity “F.” Relative ROS production induced by P. aeruginosa, 
as indicated by the change in the fluorescence of 2',7'-dichlorofluorescin (DCF), was calculated by 
using the following formula: ∆DCF fluorescence = F[PA]-F[SOD+catalase+PA] (Arbitrary Unit) where PA 
stands for P. aeruginosa. Data are presented as the mean ± SD of results from four independent 
experiments. Significant differences between infected samples and uninfected controls were 
determined by one-way ANOVA followed by Bonferroni post-hoc t-test (*, P < 0.05). Significant 
differences between infected wild-type cells and infected Cftr-deficient cells were determined by 
Student t-test (∆, P < 0.05).  
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4.3.5 Cftr deficiency and inhibition of NADPH oxidase impair bactericidal 
capability of macrophages  
To determine whether the impaired release of ROS by Cftr-deficient macrophages after 
infection with P. aeruginosa decreases the bactericidal capability of these macrophages, 
we incubated cells with P. aeruginosa at a low MOI (MOI = 1). Extracellular or attached 
bacteria were washed off by PBS and then intracellular survival of bacteria were 
determined as described in Method section. As shown in Figure 4.15, wild-type 
macrophages eliminated approximately 50% of the bacteria within 60 min when infected 
with P. aeruginosa ATCC 27853, whereas CftrMHH macrophages failed to kill the bacteria. 
Similar results were obtained with lung macrophages from CftrKO mice. The failure of 
Cftr-deficient macrophages to kill P. aeruginosa ATCC 27853 was mimicked by treating 
wild-type macrophages with the NADPH oxidase inhibitor apocynin. Similar results were 
found when wild-type or Cftr-deficient cells were infected with P. aeruginosa PAO1. 
Taken together, these findings indicate the importance of ROS for the killing of P. 
aeruginosa by macrophages. 
 
 
Figure 4.15 Cftr deficiency impairs the bactericidal capability of macrophages 
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The survival of P. aeruginosa ATCC 27853 or PAO1 strains in macrophages after infection for 60 
min is displayed. As indicated, the macrophages were pretreated with apocynin (100 µM). Data are 
presented as the mean ± SD of results from three independent experiments. Significant differences 
between P. aeruginosa ATCC 27853-infected Cftr-deficient cells or wild-type cells treated with 
apocynin and wild-type controls were determined by one-way ANOVA followed by Bonferroni 
post-hoc t-test. Significant differences between P. aeruginosa PAO1-infected Cftr-deficient cells 
and wild-type controls were analyzed by Student t-test. Significant differences (P < 0.05) are 
indicated by asterisks (*).  
4.3.6 P. aeruginosa–induced cytokine release is Cftr-independent 
Lung alveolar macrophages also play a crucial role in the production of cytokines during 
innate immune responses. Thus, we examined whether Cftr-deficient macrophages exhibit 
defects in cytokine production upon infection with P. aeruginosa. However, wild-type and 
Cftr-deficient macrophages produced similar amounts of KC and MIP2 during a 2 h 
infection with P. aeruginosa ATCC 27853 or PAO1 (Figure 4.16A and B). These data 
suggest that the production of at least some cytokines (i.e., KC and MIP2) is not a 
consequence of Cftr-deficiency in macrophages.  
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Figure 4.16 Effects of Cftr deficiency on KC and MIP2 release by alveolar macrophages upon 
infection with P. aeruginosa 
Macrophages were infected with P. aeruginosa ATCC 27853 or PAO1 strains for 2 h. Cytokine 
levels of KC (A) and MIP2 (B) in the supernatants were measured with ELISA kits (R&D 
Systems). Significant differences between infected wild-type or Cftr-deficient cells and uninfected 
wild-type or Cftr-deficient controls were determined by one-way ANOVA followed by Bonferroni 
post-hoc t-test and are indicated by asterisks (*), (P < 0.05).  
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5. DISCUSSION 
5.1 Discussion of the Methods 
5.1.1 Determination of acid sphingomyelinase activity in cell lysates 
The enzymatic activity of sphingomyelinase can be assayed by determining the conversion 
of sphingomyelin to ceramide and phosphorylcholine. However, different methods are 
used for assaying purified sphingomyelinase and cell lysates. For assaying purified 
sphingomyelinase, natural or synthetic sphingomyelin is prepared, pure or mixed with 
other lipids, in the form of extruded large unilamellar vesicles approximately 100 nm in 
diameter (Richards et al., 1986). When large unilamellar vesicles are assayed with 
sphingomyelinase, ceramide production in the bilayers leads to vesicle aggregation, which 
in turn produces an increase in turbidity or light scattering in the suspension. Thus the 
reaction can be followed in real time just by measuring the increase in turbidity 
(absorbance at 500 nm) or in light scattering (e.g. with a fluorometer with both the 
excitation and emission monochromators adjusted at 500nm). 
 
Assaying sphingomyelinase activity in cell lysates requires that sphingomyelin be labeled, 
radioactively, fluorescently or otherwise. In the present study, the enzymatic activity was 
measured as the degradation of radioactive [14C]-sphingomyelin to ceramide and [14C]-
phosphorylcholine. Because [14C]-phosphorylcholine is soluble in water, it is easily 
separated from the substrate [14C]-sphingomyelin and ceramide, which stays in organic 
phase following extraction. Sphingomyelin serves as substrate for three forms of 
sphingomyelinases that manifest acid, neutral or basic pH optima for maximal enzyme 
activity (Hannun, 1996). In the present study acid sphingomyelinase activity was 
discriminated from the neutral or basic sphingomyelinase activity by performing the assay 
at pH 5.0. Because of the difficulty in bringing together the enzyme and substrate 
molecules in the presence of cell homogenates, a suitable detergent, such as Triton X-100 
was used. It should be noted that, apart from emulsifying the substrate, the detergents bind 
and modify the enzyme activity, thus detergent concentration and initial detergent : 
substrate ratio was kept constant for reproducibility of assays. Finally, it has been 
suggested that the acid sphingomyelinase may be located in detergent-resistant/insoluble 
fractions; thus, for determination of acid sphingomyelinase activity in whole-cell lysates, 
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no centrifugation step was performed after lysis and sonication of the cells to prevent 
pelleting and loss of the acid sphingomyelinase. 
 
5.1.2 Ceramide measurement by DAG-kinase assay 
In the literature, there are several methods reported for quantifying ceramide such as 
normal phase HPLC analysis after derivatization with a fluorescent tag (Iwamori et al., 
1979; Previati et al., 1996; Yano et al., 1998; Couch et al., 1997), evaporative light-
scattering detection (McNabb et al., 1999), HPTLC analysis (Motta et al., 1994), or using 
cells labeled with radioactive precursors (Tepper et al., 2000; Allan, 2000). Ceramide 
molecular species can be determined following hydrolysis and analysis of the liberated and 
derivatized sphingoid bases by means of HPLC (Smith and Merril, 1995; Nishimura and 
Nakamura, 1985) and fatty acids by means of GC/MS (Samuelsson and Samuelsson, 1970). 
New quantitative analysis of ceramide molecular species are based on HPLC or RP-HPLC 
separation of their fluorescent analogs prepared after derivatization with anthroyl cyanide 
(Yano et al., 1998), benzoyl chloride (Couch et al., 1997), or benzoic anhydride (Iwamori 
et al., 1979). Moreover, mass spectrometry methodologies have been developed for the 
detection of molecular species of ceramide (Watts et al., 1999; Couch et al., 1997; Allan D., 
2000; Kalhorn and Zager, 1999; Mano et al., 1997; Gu et al., 1997; Liebisch et al., 1999; 
Karlsson et al., 1998). However, most of these methods require long periods of processing 
and/or analysis.  
 
The DAG-kinase assay is a widely used method for the rapid quantification of ceramides. 
The primary advantages of the DAG kinase assay are the measurement of total mass levels 
of ceramide; the use of crude lipid extracts in the assay; and the ability of process a large 
number of samples in a rapid manner. DAG kinase was used as an analytical tool in 
measuring diglyceride levels by the demonstration of a linear relationship between the 
amount of diglyceride added to an in vitro assay and the amount of product (phosphatidic 
acid) formed. Ceramides share structural similarities with diglycerides, and Schneider and 
Kennedy reported that bacterial DAG kinase can utilize ceramide as a substrate with a Km 
nearly five times greater than that for diglyceride (Schneider and Kennedy, 1973). Early 
attempts to use DAG kinase to quantify ceramide revealed a linear but non-quantitative 
relationship between substrate added and product formed. Further modification of the 
assay demonstrated that DAG kinase could also be used for quantitative conversion of 
ceramide to ceramide-1-phosphate over a range of 25 pmol to 2 nmol (van Veldhoven et al., 
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1995). These refinements have required special emphasis on the protocol of lipid 
extraction, purity of the reagents used for the preparation of the mixed micelles and on the 
development of high levels of recombinant DAG kinase. 
 
Because ceramide is highly hydrophobic, it should be extracted from cells in organic 
solvents. Thus, the cells are lysed in a solution containing chloroform and methanol. 
Acidification of lysates with hydrochloric acid helps extraction of shorter acyl chain 
ceramide-1-phosphates or hydroxylated ceramides. For the DAG kinase reaction, it is 
critical that the substrate is in a soluble form for optimal conversion to product by the 
enzyme. Mixed micelles containing a non-ionic detergent, such as n-octyl-ß-D-
glucopyranoside, and a phosholipid, such as cardiolipin, are utilized for this purpose. Of 
particular importance is the level of ceramide conversion to ceramide-1-phosphate. For the 
DAG kinase assay to yield reliable quantitative results, the reaction must go to completion 
with total conversion of DAG and ceramide. Otherwise, the results become sensitive to the 
effects of the efficiency of the reaction (Km and Vmax consideration of the DAG kinase) and 
to possible ‘competition’ between DAG and ceramide as substrates. In the present study, 
an excess of enzyme and ATP was used which allowed linear and quantitative conversion 
and was sufficient for the phosphorylation of cellular ceramides as well as exogenously 
added ceramide.  
  
5.1.3 Analysis of aggregated molecules and co-localized signals 
The present study used fluorescent microscopical analysis to detect the co-localization of 
two molecules or two vesicles after staining with the respective fluorochrome-labeled 
antibodies or fluorescent markers. One application is to determine whether gp91phox 
clusters in ceramide-enriched membrane platforms. The major problem in detection of 
aggregated molecules onto the plasma membrane is the possibility of superposition of two 
or more membranes within the microscopical field of interest. This would lead to an 
amplification of the fluorescent signal and a false-positive result. To avoid this artifact, 
alveolar macrophages were plated with appropriate density and no clustered cells were 
observed in our preparation. Another critical point to detect membrane ceramide-enriched 
platforms is to avoid usage of detergents that usually used to permeablize cell membrane 
such as 0.1% Triton X-100.  
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When two or more stainings are performed simultaneously, the fluorescence signals might 
be recorded in one detection channel and might no longer be separated in the images. This 
is called ‘cross-talk’ of the fluorescence signals. Apart from preparing single-stained 
specimens as controls, ‘sequential image analysis’ of the respective samples by confocal 
microscopy was employed to rule out these false-positive data. The advantage of 
sequential analysis regarding multiple stainings lies in the ability to record a certain optical 
section using an instrument parameter settings (detection channel and excitation 
wavelength) adapted to one fluorochrome, before the system switches to different 
instrument parameter settings adapted for another fluorochrome. Therefore, this method is 
particularly useful to exclude the cross-talk between multiple fluorescent signals.  
 
5.1.4 Bactericidal capability assay 
To assay the capability of phagocytes to kill internalized P. aeruginosa, phagocytes are 
usually infected with high MOI of bacteria and then incubated with antibiotics such as 
gentamycin to kill extracellular bacteria. After removal of antibiotics by several washes, 
phagocytes are incubated further to allow intracellular killing of bacteria. This antibiotic-
dependent method has been widely used based on the fact that the plasma membrane of 
mammalian cells are impermeable to antibiotics. However, there is concern that the 
antibiotics can enter into cells via endocytosis or phagocytosis and thereby affect killing of 
internalized bacteria. To avoid this artifact, the present study developed an antibiotic-free 
method. The alveolar macrophages were infected with low MOI of P. aeruginosa (MOI= 
1). The usage of low MOI infection allows macrophages to phagocytose most of bacteria 
and subsequent easy removal of the extracellular bacteria.  
 
5.2 Discussion of the Results 
5.2.1 Role of acid sphingomyelinase and ceramide in redox signalling 
The present study demonstrates that acid sphingomyelinase plays a critical role in P. 
aeruginosa-triggered ROS release. The results show that P. aeruginosa infection induces 
rapid activation of acid sphingomyelinase and consequent ceramide release in membranes 
of macrophages. P. aeruginosa induces respiratory ROS burst and time-dependent ROS 
accumulation in macrophages. These events were all absent in Smpd1-/- mice that are 
deficient in acid sphingomyelinase activity. Consistently, Reinehr and co-workers 
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demonstrated that inhibiting acid sphingomyelinase blocks the release of ROS, a finding 
suggesting that ROS functions downstream of acid sphingomyelinase in hepatocytes 
(Reinehr et.al., 2006). Similarly, inhibiting acid sphingomyelinase attenuates the ceramide 
and ROS production induced by histone deacetylase/perifosin, fenretinide, or sodium 
nitroprusside (Lovat et.al., 2004; Rahmani et.al., 2005; Sanvicens and Cotter, 2006). Taken 
together, these data confirmed the notion that acid sphingomyelinase activation and 
ceramide production are upstream signals of ROS production. 
 
Ceramide induces the activation of ROS-generating enzymes, including NADPH oxidase, 
xanthine oxidase, NO synthase, and the mitochondrial respiratory chain (Corda et.al., 2001; 
Lecour et.al., 2006; Zhang et.al., 2001). In particular, ceramide has been shown to activate 
NADPH oxidase and to increase the production of ROS in a variety of mammalian cells, 
including human aortic smooth muscle cells and endothelial cells (Bhunia et.al., 1997; 
Zhang et.al., 2007). The precise mechanism that how ceramide activates NADPH oxidase 
is not well understood. Because NADPH oxidase activation requires aggregation of its 
subunits, it has been proposed that ceramide mediates the fusion of small raft domains to 
ceramide-enriched membrane platforms, which facilitate the aggregation of subunits of 
NADPH oxidase, thereby stimulating the production of ROS (Zhang et.al., 2006).  
 
The present data suggest that a similar role of ceramide in NADPH oxidase activation 
exists in macrophages during P. aeruginosa infection. Inhibition of NADPH oxidase 
activity by DPI abolished P. aeruginosa-induced ROS production suggesting that NADPH 
oxidase is the major ROS-generating enzyme regulated by acid sphingomyelinase and 
ceramide in alveolar macrophages. The activation of acid sphingomyelinase results in 
release of ceramide that forms ceramide-enriched membrane platforms serving to 
aggregate NADPH oxidase and, thus, to produce ROS. These events were all absent in 
Smpd1-/- mice that are deficient in acid sphingomyelinase activity.  
 
At present it is unknown how ceramide-enriched membrane platforms contribute to 
NADPH oxidase activation. It can be hypothesized that aggregation of subunits of NADPH 
oxidase in ceramide-enriched membrane platforms enhances interactions between subunits 
of NADPH oxidase, thereby stimulating the production of ROS. Ceramide in platforms 
may also directly enhance NADPH oxidase activity by activating small G protein Rac1/2 
by activation of guanine nucleotide exchange factors (GEFs) such as Vav2 (Yi F et.al., 
2007). 
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5.2.2 Role of ROS in acid sphingomyelinase activation 
Several recent studies have demonstrated that the generation of ROS activates acid 
sphingomyelinase in response to various stimuli (Scheel-Toellner et.al., 2004; Charruyer 
et.al., 2005), which seems to conflict with the above conclusion that acid sphingomyelinase 
activation results in ROS production. This conundrum is discussed below and an 
amplifying concept is presented.  
 
Scheel-Toellner and colleagues demonstrated that acid sphingomyelinase activation, 
ceramide generation, and CD95 clustering play a crucial role in the spontaneous apoptosis 
of neutrophils; apoptosis was substantially delayed in acid sphingomyelinase-deficient 
mice (Scheel-Toellner et.al., 2004). On the basis of the observation that the intracellular 
redox balance changes in aging neutrophils, the authors investigated the possibility that 
ROS may be involved in acid sphingomyelinase activation. Their study demonstrated that 
pretreating neutrophils with the antioxidants N-acetylcysteine and desferrioxamine 
substantially inhibited the events downstream of acid sphingomyelinase activation, such as 
ceramide generation and CD95 clustering, thus indicating that ROS release is required for 
acid sphingomyelinase activation (Scheel-Toellner et.al., 2004). Similarly, pretreatment 
with the antioxidant pyrrolidine dithiocarbamate abolished acid sphingomyelinase 
activation by ultraviolet (UV)-C light in U937 cells (Charruyer et.al., 2005).  
 
Neuronal stimulation with soluble oligomers of amyloid-beta peptide results in the release 
of ROS and the subsequent activation of the sphingomyelinases (Malaplate-Armand et.al., 
2006). The authors demonstrated that both the acid and the neutral sphingomyelinases play 
a crucial role in neuronal apoptosis induced by amyloid-beta oligomers, as shown by 
enzymatic activity assays, neutral and acid sphingomyelinase inhibitors, and antisense 
oligonucleotides for gene knockdown. Because treatment with antioxidant molecules and a 
cPLA2-specific inhibitor or antisense oligonucleotide led to inhibition of sphingomyelinase 
activation and subsequent apoptosis, the results of their study suggest that amyloid-beta 
oligomers induce neuronal death by activating neutral and acid sphingomyelinases in a 
redox-sensitive cPLA2-arachidonic acid pathway (Malaplate-Armand et.al., 2006).  
 
Dumitru and colleagues have recently demonstrated the involvement of ROS in TRAIL-
induced activation of acid sphingomyelinase and apoptosis (Dumitru et.al., 2006). 
Stimulation with TRAIL/DR5 led to the activation of acid sphingomyelinase and the 
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subsequent formation of ceramide-enriched membrane platforms, DR5 clustering, and, 
finally, apoptosis. Pretreatment with the antioxidants N-acetylcysteine and Tiron 
substantially inhibited TRAIL-induced acid sphingomyelinase activation, ceramide/DR5 
clustering, and apoptosis, thus demonstrating the important role of ROS in this signaling 
pathway (Dumitru et.al., 2006). Finally, studies investigating the cellular effects of Cu2+ 
showed that Cu2+ also promotes the ROS-dependent activation of acid sphingomyelinase 
and leads to the death of hepatocytes (Lang et.al., 2007). The results of these studies 
demonstrate that the accumulation of Cu2+, as in Wilson disease, activates acid 
sphingomyelinase in hepatocytes and triggers the release of ceramide in these cells. This 
process results in Cu2+-induced hepatocyte death, which can be prevented by a deficiency 
in acid sphingomyelinase (Lang et.al., 2007). 
 
The above-mentioned studies demonstrate that ROS are involved in the activation of acid 
sphingomyelinase; however, direct oxidation of the enzyme has been described only in a 
biochemical study by Qiu and co-workers (Qiu et al., 2003). The authors demonstrated that 
C-terminal cysteine (Cys629) plays a crucial role in the enzymatic activity of recombinant 
human acid sphingomyelinase (rhASM). In particular, it appears that any change that 
causes a loss of the free sulfhydryl group on this amino acid also results in activation of the 
enzyme: i.e., copper-promoted dimerization of rhASM by C-terminal cysteine, thiol-
specific chemical modification of this cysteine to form a mixed disulfide bond or a 
sulphur-carbon linkage, deletion of this cysteine by carboxypeptidase or recombinant DNA 
technology, and site-specific mutation to change the cysteine to a serine residue.  
 
Because zinc is required for acid sphingomyelinase activity, the authors proposed a model 
that explains the effect of C-terminal cysteine modification on the activation of acid 
sphingomyelinase. In its low-activity form, free C-terminal cysteine is involved in active-
site zinc coordination, either by competing with a water molecule for coordination with 
zinc or by forming a non-optimal 5-ligand coordination structure. Thus, C-terminal 
cysteine decreases zinc’s ability to ionize water for the nucleophilic attack and decreases 
enzymatic activity. Because thiol is a better zinc ligand than water, the non-optimal 
structure may be energetically favorable as long as the cysteine is freely available. In the 
high-activity form of rhASM, however, the free cysteine is lost either by either chemical 
modification or by deletion and is no longer available for coordination. As a result, zinc 
coordinates with a water molecule to produce an optimal structure for catalysis. This model 
is essentially identical to the “cysteine switch” activation mechanism described previously 
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for the matrix metalloproteinase family (Van Wart et al., 1990). Although the “terminal 
cysteine” model could explain the effect of ROS on the mechanism of acid 
sphingomyelinase activation, the requirement of dimerization, further molecular events, or 
both for enzyme stimulation in vivo should be addressed in future studies.  
 
In summary, these studies demonstrate that acid sphingomyelinase activity is regulated by 
ROS. Therefore, we proposed an amplification model for acid sphingomyelinase activation 
and ROS production upon P. aeruginosa infection. In this amplification model, initial 
activation of acid sphingomyelinase results in produce ROS, which further enhance 
activation of acid sphingomyelinase thus forms a feed-forward loop for ROS production.  
 
5.2.3 Role of ceramide-enriched membrane platform in amplification of redox 
signaling  
The present study demonstrates that ceramide-enriched platforms play a critical role in a 
feed-forward loop in amplifying NADPH oxidase-derived redox signaling. In this feed-
forward loop, a primarily weak acid sphingomyelinase activation is enhanced by the 
production of ROS resulting in higher acid sphingomyelinase-activity and efficient 
formation of ceramide-enriched platforms and, thus, also NADPH oxidase activation. This 
feed-forward loop notion is supported by the facts that DPI (inhibiting NADPH oxidase 
activity) or catalase (a ROS degrading enzyme), not only inhibited P. aeruginosa–induced 
acid sphingomyelinase activation, but also prevented acid sphingomyelinase-mediated 
ceramide-enriched platform formation. It is of note that NADPH oxidase inhibition did not 
completely block acid sphingomyelinase activity. Further, acid sphingomyelinase 
activation preceded the release of ROS indicating that the bacteria stimulate acid 
sphingomyelinase via unknown mechanism resulting in ROS release, which then oxidize 
acid sphingomyelinase to promote further stimulation of the enzyme. As discussed above, 
ROS probably enhances activation of acid sphingomyelinase by dimerization of a cysteine 
residue to form disulfide bonds (Qiu et al., 2003). The feed-forward loop notion is further 
supported by the present finding that H2O2, a stable and cell permeable ROS, activates acid 
sphingomyelinase and induces formation of ceramide-enriched platform in wild type 
macrophages, whereas no platforms formed in Smpd1¯/¯ cells. Taken together, acid 
sphingomyelinase, ceramide-enriched membrane platform, NADPH oxidase and ROS 
constitute a feed-forward loop resulting in a rapid and efficient amplification of NADPH 
oxidase activity and ROS production.  
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A similar model has been proposed for regulation of caspase 8 activation by acid 
sphingomyelinase, with a primary weak activation of caspase 8 and a feed-forward loop by 
acid sphingomyelinase. It has been shown that CD95 ligation, which releases ROS for the 
induction of apoptosis (Um et al., 1996; Gulbins et.al., 1996; Reinehr et al., 2006), 
primarily induces a very weak recruitment of FADD and the stimulation of caspase 8; 
however, this stimulation reaches only approximately 1% of the levels that are observed 
for maximal activation of caspase 8 (Grassmé et al., 2003). This weak activation of caspase 
8 is observed in acid sphingomyelinase-deficient cells, but it is insufficient to trigger 
apoptosis in these cells. However, the low activity of caspase 8 is sufficient to trigger the 
translocation and activation of acid sphingomyelinase within seconds, with the subsequent 
formation of ceramide-enriched membrane platforms that cluster CD95 (Grassmé et al., 
2003). Receptor clustering leads to the formation of death-inducing signaling complex 
(DISC) and full activation of caspase 8.  
 
Membrane rafts and ceramide were identified to have an important function in infectious 
biology. Many pathogens target and employ rafts for infection of cells, including 
Escherichia coli, Mycobacterium tuberculosis, Campylobacter jejuni, Vibrio cholerae and 
P. aeruginosa (Grassmé et al., 2001). However, the molecular mechanisms of raft-
mediated infection of mammalian cells with pathogens are largely unknown. Our data 
suggest that membrane rafts, at least, are involved in host-defense interaction by regulating 
ROS production. 
 
5.2.4 Role of Cftr in lysosomal alkalinization  
The present study demonstrates that freshly isolated lung macrophages contain at least two 
distinct acidic vesicle populations. Some, but not all of these vesicles exhibit a higher pH 
in Cftr-deficient macrophages than the corresponding vesicles in wild-type cells, as 
indicated by staining with Lysosensor Green DND-189 and DND-153.   
 
It has been suggested that CFTR regulates pH in at least some intracellular vesicles 
(Barasch et.al., 1991; Poschet et.al., 2002; Di et.al., 2006; Teichgräber et.al., 2008; Deriy 
et.al., 2009). The acidification of intracellular vesicles requires high concentrations of 
protons within the vesicles; these concentrations are achieved by the activity of proton 
pumps, in particular the V-type adenosine triphosphatase (v-ATPase) proton pump 
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(Jefferies et.al., 2008). Because the v-ATPase protein pump is electrogenic, its activity 
requires either the accumulation of negatively charged counterions in these vesicles or the 
active transport of other positively charged ions out of the vesicular lumen (Mellman et.al., 
1986). It has been proposed that CFTR mediates this influx of counterions into at least 
some intracellular vesicles (Barasch et.al., 1991; Di et.al., 2006; Deriy et.al., 2009) (Figure 
5.1). 
 
 
 
Figure 5.1 Proposed model of Cftr in controlling lysososmal pH and chronic accumulation of 
ceramide in Cftr-deficient lysosomes. 
 
However, the role of Cftr in the regulation of vesicular pH is controversial. Barasch and 
Al-Awqati demonstrated the alkalinization of trans-Golgi and mannose-6-phosphate–
positive vesicles and prelysosomes in Cftr-deficient cells (Barasch et al., 1991). These 
findings were confirmed by the results of several studies that demonstrated the 
alkalinization of lysosomes and phagosomes in alveolar macrophages (Barasch et.al., 1991; 
Di et al., 2006; Deriy et.al., 2009). In contrast, other reports have failed to detect a role of 
Cftr in the regulation of pH in vesicles that form after internalization (Haggie et al., 2009; 
Barriere et al., 2009). These studies determined the pH in TMR-dextran–positive 
endosomes or vesicles that contain internalized antibody-labelled or fluorescent Cftr 
molecules (Haggie et al., 2009; Barriere et.al., 2009). Dextran-containing endosomes are 
directly targeted to a subpopulation of lysosomes, and these endosomes are distinct from 
mannose-6-phosphate–positive vesicles and do not mix with secretory lysosomes 
(Stoorvogel et al., 1989). The discrepancies in findings about the role of Cftr in the 
regulation of vesicular pH could be caused by the fact that the reported studies used 
different cell systems and different techniques. Moreover, different types of vesicles 
express different sets of ion channels and pumps (Bradbury et al., 1999), and this fact very 
likely explains the differences in the effects of CFTR deficiency on the pH of a particular 
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population of vesicles. The findings of the present study confirm the notion that Cftr is 
involved in the regulation of the pH in a subset of intracellular vesicles, most likely 
secretory lysosomes.  
  
Changes in the pH of secretory lysosomes may result in a relative overactivity of acid 
sphingomyelinase, which is still active at a pH of 6.0, in comparison to that of acid 
ceramidase, which is almost inactive at pH 6.0; this overactivity might be followed by a 
slow accumulation of ceramide in these vesicles of Cftr-deficient cells (Teichgräber et al., 
2008) (Figure 5.1). Indeed, we observed a marked chronic accumulation of ceramide in 
Cftr-deficient alveolar macrophages. In addition, Cftr-deficiency prevented the acute and 
rapid activation of acid sphingomyelinase observed in wild-type cells after infection with P. 
aeruginosa (Yu et al., 2009), thereby preventing the acute release of ceramide upon 
infection. On the basis of these observations, we assume that the LysoSensor Green DND-
189–positive lysosomes are secretory lysosomes containing the signaling pool of acid 
sphingomyelinase, that their vesicular pH is regulated by Cftr and that the increase in the 
pH of secretory lysosomes prevents activation of the acid sphingomyelinase. In contrast, 
the lysosomal form of acid sphingomyelinase, which mediates the physiological steady-
state metabolism of sphingomyelin, does not seem to be affected in Cftr-deficient cells, 
since classical lysosomes in Cftr-deficient cells do not seem to exhibit an accumulation of 
sphingomyelin.  
 
The present study further explored whether the influence of Cftr deficiency is linked to 
alterations in lysosomal biogenesis and transport. We did not detect a difference in staining 
with LAMP1 between wild-type and Cftr-deficient macrophages; this finding suggests that 
lysosome biogenesis is not altered in the absence of Cftr. The finding that Cftr co-localizes 
with LAMP1 further supports the hypothesis that Cftr resides in the lysosomal membrane 
and is directly involved in the acidification of lysosomes. Finally, Cftr deficiency exerted 
no effect on TMR-dextran staining. Because TMR-dextran is internalized by endocytosis 
and released by vesicular exocytosis, TMR-dextran staining in the cells reflects 
equilibrium between endocytosis and vesicular exocytosis. Thus, our findings indicate that 
the formation of endocytotic and secretory vesicles is not altered by Cftr deficiency. Taken 
together, our findings strongly suggest that Cftr is directly involved in the regulation of pH 
in a specific subpopulation of lysosomes but is not involved in lysosomal biogenesis or the 
formation of endocytic and secretory vesicles in lung alveolar macrophages.  
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However, it is also possible that Cftr deficiency affects the pH on the extracellular leaflet 
of the cell membrane and thereby alters the balance between acid sphingomyelinase and 
acid ceramidase. Moreover, it is possible that Cftr deficiency prevents the acute activation 
of acid sphingomyelinase by P. aeruginosa because it alters the lipid content of secretory 
lysosomes. Previous studies by Tabas and colleagues demonstrated that the lipid 
composition of membranes has a substantial impact on the activation of acid 
sphingomyelinase (Schissel et al., 1998). It remains to be determined whether alterations of 
other membrane lipids in Cftr-deficient cells contribute to the defect of acid 
sphingomyelinase activation in these cells.  
 
5.2.5 Role of Cftr in regulation of redox signaling 
Activation of the acid sphingomyelinase seems to occur in secretory lysosomes that fuse 
with the cell membrane (Grassmé et al., 2003; Jin et al., 2008). Ceramide then forms 
ceramide-enriched membrane platforms in the plasma membrane; these platforms serve the 
clustering and activation of NADPH oxidase and, thus, the release of ROS. The present 
study shows that P. aeruginosa–induced ROS release requires acute activation of acid 
sphingomyelinase and is abolished in Cftr-deficient macrophages. These data support the 
view that deficiency of Cftr results in alkalnization of secretory lysosomes and consequent 
prevention of acid sphingomyelinase activation and ceramide-mediated ROS production. 
 
The role of Cftr in redox signaling seems to specific for bacterial infection (at least for P. 
aeruginosa). Di and co-workers show that Cftr deficiency does not affect phorbol 12-
myristate l3-acetate (PMA)-induced ROS production in alveolar macrophages (Di et al., 
2006). It is well accepted that p47phox phosphorylation and translocation is a crucial for 
agonist (such as PMA)-induced NADPH oxidase activation and ROS production in many 
mammalian cells. PMA is a potent stimulator for PKC, which phosphorylates p47phox and 
induces translocation of this crucial subunit of NADPH oxidase to the plasma membrane. 
Thus, PMA increases ROS production by direct activation of NADPH oxidase and does 
not require a function of Cftr.  
 
Recent data suggest that Cftr is also involved in regulation of redox signaling by 
antioxidant mechanisms. IHoste and colleagues demonstrated that Cftr and ROS are 
involved in staurosporine-induced apoptosis of renal cells immortalized from primary 
cultures of proximal convoluted tubules (IHoste et.al., 2010). Staurosporine induced 
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increase in ROS in wild-type cells, which was impaired by a specific CFTR inhibitor 
(CFTR(inh)-172) and was not observed in Cftr-deficient cells. Because Cl– and GSH share 
common permeation through CFTR, the role probably involves control of the intracellular 
ROS balance by Cftr-dependent regulation of GSH concentration (Kogan et.al., 2003). 
 
ROS are toxic to most bacteria including P. aeruginosa. In vivo, lung bacteria clearance of 
P. aeruginosa was impaired in Smpd1-/-, p47phox-/- or Cftr-/- mice compared to wild type 
mice (Grassmé et al., 2003; Sadikot et al., 2004; Teichgräber et al., 2008). The present 
study shows that the impairment in ROS release by Cftr-deficient macrophages decreases 
the bactericidal capability of these cells against P. aeruginosa. Thus, the present finding 
links the function of ceramide-enriched redox-signaling platforms with the bactericidal 
activity in alveolar macrophages. In contrast, Cftr deficiency does not affect the cytokine 
release response by these lung macrophages, a finding that is consistent with those of 
previous studies showing that Cftr is not involved in the production of cytokines (KC and 
MIP2) by LPS-stimulated macrophages (Kostyk et al., 2006). This situation is in marked 
contrast to that in Cftr-deficient epithelial cells, which show a marked increase in the 
constitutive release of pro-inflammatory cytokines such as IL-1 and IL-8 (Teichgräber et 
al., 2008; Tabary et al., 1998; Stecenko et al., 2001).  
 
At present, the role of macrophages in cystic fibrosis is poorly defined. Although several 
studies have demonstrated that Cftr-deficient macrophages exhibit a defect in the 
intracellular killing of P. aeruginosa (Di et al., 2006; Deriy et al., 2009), the role of 
macrophages in acute pulmonary infections with P. aeruginosa in vivo is still open (Koh et 
al., 2009). A recent study demonstrated that in particular neutrophils are essential in 
eliminating P. aeruginosa from infected airways (Koh et al., 2009). Thus, macrophages 
might be important in regulating pathways which enhance inflammation including 
amplification of neutrophil recruitment. It is also possible that the inability of Cftr-
deficient macrophages to kill sufficient numbers of P. aeruginosa bacteria contributes to 
the initial sensitivity of cystic fibrosis patients (and mice) to infections with P. aeruginosa, 
a situation that does not apply to wild-type mice. This defect in Cftr-deficient macrophages 
may result in a slow removal of the bacteria from alveoli, a longer persistence of the 
bacteria in the lung and finally the growth of the bacteria in the lung. It could be speculated 
that the survival of P. aeruginosa in Cftr-deficient macrophages may protect the pathogens 
from the neutrophil attack in cystic fibrosis. However, determining whether this hypothesis 
is true will require future studies that are beyond the focus of the present study; such 
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studies will probably use floxed Cftr-deficient mice with a specific deficiency of Cftr in 
macrophages to exactly define the function of alveolar macrophages in cystic fibrosis.  
 
5.2.6 Significances and perspectives 
The major significance of the research work in this dissertation was to clarify the role of 
ceramide-mediated redox signaling in the regulation of macrophage function in the host 
defense response in cystic fibrosis. The results presented in this dissertation increases our 
understanding of the signaling mechanisms responsible for the acute ROS response in 
macrophages during host-pathogen interaction and link the function of Cftr with ceramide-
redox signaling. The notion that Cftr deficiency impairs ceramide-mediated redox 
signaling and normal macrophage function may contribute to the understanding why cystic 
fibrosis patients are susceptible to P. aeruginosa infections. This notion will also inspire 
studies about the role of NADPH oxidase enzyme family in mediating cellular functions of 
other cells in pulmonary systems. Elucidation of the pathogenesis of cystic fibrosis 
associated with the ceramide-redox signaling may direct the development of new 
therapeutic strategy for treatment of this disease.  
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6. SUMMARY 
The present study first investigated the role of acid sphingomyelinase and ceramide-
enriched membrane platforms in P. aeruginosa-induced redox signaling in lung alveolar 
macrophages. The major findings are: 
 
• P. aeruginosa rapidly activates acid sphingomyelinase and induces ceramide release in 
the plasma membranes.  
• Acid sphingomyelinase mediates P. aeruginosa–induced ROS production.  
• Acid sphingomyelinase activation by P. aeruginosa infections results in formation of 
ceramide-enriched membrane platforms.  
• Ceramide-enriched membrane platforms are crucial for aggregation and activation of 
NADPH oxidase.  
• Acid sphingomyelinase-mediated redox signaling is strongly amplified via a positive 
feedback mechanism in ceramide-enriched membrane platforms.  
 
The proposed signaling pathway is depicted as bellow:  
 
 
 
 
 
 
 
 
 
Furthermore, the present study investigated whether Cftr is involved in acidification of 
lysosomes and therefore involved in acid sphingomyelinase-mediated redox signaling in 
lung alveolar macrophages. The major findings are:   
 
• Cftr deficiency results in alkalinization of a subset of vesicles, which include secretory 
lysosomes. 
• Cftr deficiency results in a chronic accumulation of ceramide in macrophages, but 
prevents the acute release of ceramide upon infection with P. aeruginosa. 
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• Cftr deficiency results in failure to stimulate the activation of NADPH oxidase and, 
thus, an inability to release ROS and to kill P. aeruginosa. 
 
The proposed pathway is depicted as bellow: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
* Asm: acid sphingomyelinase; Acd: acid ceramidase 
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